<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 14 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:inherit;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	line-height:115%;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";}
h1
	{mso-style-link:"Heading 1 Char";
	margin-right:0in;
	margin-left:0in;
	font-size:24.0pt;
	font-family:"Times New Roman","serif";
	font-weight:bold;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-right:0in;
	margin-left:0in;
	font-size:18.0pt;
	font-family:"Times New Roman","serif";
	font-weight:bold;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-right:0in;
	margin-left:0in;
	font-size:13.5pt;
	font-family:"Times New Roman","serif";
	font-weight:bold;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
p
	{margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:8.0pt;
	font-family:"Tahoma","sans-serif";}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Times New Roman","serif";
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Times New Roman","serif";
	font-weight:bold;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Times New Roman","serif";
	font-weight:bold;}
p.ui-button, li.ui-button, div.ui-button
	{mso-style-name:ui-button;
	margin-right:1.2pt;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-spinner, li.ui-spinner, div.ui-spinner
	{mso-style-name:ui-spinner;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-spinner-input, li.ui-spinner-input, div.ui-spinner-input
	{mso-style-name:ui-spinner-input;
	margin-top:2.4pt;
	margin-right:16.5pt;
	margin-bottom:2.4pt;
	margin-left:4.8pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-helper-hidden-accessible, li.ui-helper-hidden-accessible, div.ui-helper-hidden-accessible
	{mso-style-name:ui-helper-hidden-accessible;
	margin-top:0in;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-buttonset, li.ui-buttonset, div.ui-buttonset
	{mso-style-name:ui-buttonset;
	margin-right:5.25pt;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker, li.ui-datepicker, div.ui-datepicker
	{mso-style-name:ui-datepicker;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	display:none;}
p.ui-datepicker-row-break, li.ui-datepicker-row-break, div.ui-datepicker-row-break
	{mso-style-name:ui-datepicker-row-break;
	margin-right:0in;
	margin-left:0in;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-rtl, li.ui-datepicker-rtl, div.ui-datepicker-rtl
	{mso-style-name:ui-datepicker-rtl;
	margin-right:0in;
	margin-left:0in;
	text-align:right;
	direction:rtl;
	unicode-bidi:embed;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-menu, li.ui-menu, div.ui-menu
	{mso-style-name:ui-menu;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-progressbar, li.ui-progressbar, div.ui-progressbar
	{mso-style-name:ui-progressbar;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-resizable-handle, li.ui-resizable-handle, div.ui-resizable-handle
	{mso-style-name:ui-resizable-handle;
	margin-right:0in;
	margin-left:0in;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";}
p.ui-resizable-n, li.ui-resizable-n, div.ui-resizable-n
	{mso-style-name:ui-resizable-n;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-resizable-s, li.ui-resizable-s, div.ui-resizable-s
	{mso-style-name:ui-resizable-s;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-resizable-e, li.ui-resizable-e, div.ui-resizable-e
	{mso-style-name:ui-resizable-e;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-resizable-w, li.ui-resizable-w, div.ui-resizable-w
	{mso-style-name:ui-resizable-w;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-resizable-se, li.ui-resizable-se, div.ui-resizable-se
	{mso-style-name:ui-resizable-se;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-resizable-sw, li.ui-resizable-sw, div.ui-resizable-sw
	{mso-style-name:ui-resizable-sw;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-resizable-nw, li.ui-resizable-nw, div.ui-resizable-nw
	{mso-style-name:ui-resizable-nw;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-resizable-ne, li.ui-resizable-ne, div.ui-resizable-ne
	{mso-style-name:ui-resizable-ne;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-selectable-helper, li.ui-selectable-helper, div.ui-selectable-helper
	{mso-style-name:ui-selectable-helper;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-selectmenu-menu, li.ui-selectmenu-menu, div.ui-selectmenu-menu
	{mso-style-name:ui-selectmenu-menu;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	display:none;}
p.ui-selectmenu-open, li.ui-selectmenu-open, div.ui-selectmenu-open
	{mso-style-name:ui-selectmenu-open;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-selectmenu-button, li.ui-selectmenu-button, div.ui-selectmenu-button
	{mso-style-name:ui-selectmenu-button;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-slider, li.ui-slider, div.ui-slider
	{mso-style-name:ui-slider;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-slider-horizontal, li.ui-slider-horizontal, div.ui-slider-horizontal
	{mso-style-name:ui-slider-horizontal;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-slider-vertical, li.ui-slider-vertical, div.ui-slider-vertical
	{mso-style-name:ui-slider-vertical;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-spinner-button, li.ui-spinner-button, div.ui-spinner-button
	{mso-style-name:ui-spinner-button;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:6.0pt;
	font-family:"Times New Roman","serif";}
p.ui-tooltip, li.ui-tooltip, div.ui-tooltip
	{mso-style-name:ui-tooltip;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-state-default, li.ui-state-default, div.ui-state-default
	{mso-style-name:ui-state-default;
	margin-right:0in;
	margin-left:0in;
	background:#E6E6E6;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#555555;}
p.ui-state-focus, li.ui-state-focus, div.ui-state-focus
	{mso-style-name:ui-state-focus;
	margin-right:0in;
	margin-left:0in;
	background:#DADADA;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#212121;}
p.ui-state-hover, li.ui-state-hover, div.ui-state-hover
	{mso-style-name:ui-state-hover;
	margin-right:0in;
	margin-left:0in;
	background:#DADADA;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#212121;}
p.ui-state-active, li.ui-state-active, div.ui-state-active
	{mso-style-name:ui-state-active;
	margin-right:0in;
	margin-left:0in;
	background:white;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#212121;}
p.ui-state-highlight, li.ui-state-highlight, div.ui-state-highlight
	{mso-style-name:ui-state-highlight;
	margin-right:0in;
	margin-left:0in;
	background:#FBF9EE;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#363636;}
p.ui-state-error, li.ui-state-error, div.ui-state-error
	{mso-style-name:ui-state-error;
	margin-right:0in;
	margin-left:0in;
	background:#FEF1EC;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#CD0A0A;}
p.ui-state-error-text, li.ui-state-error-text, div.ui-state-error-text
	{mso-style-name:ui-state-error-text;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#CD0A0A;}
p.ui-priority-primary, li.ui-priority-primary, div.ui-priority-primary
	{mso-style-name:ui-priority-primary;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	font-weight:bold;}
p.ui-priority-secondary, li.ui-priority-secondary, div.ui-priority-secondary
	{mso-style-name:ui-priority-secondary;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-state-disabled, li.ui-state-disabled, div.ui-state-disabled
	{mso-style-name:ui-state-disabled;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-helper-hidden, li.ui-helper-hidden, div.ui-helper-hidden
	{mso-style-name:ui-helper-hidden;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	display:none;}
p.ui-helper-reset, li.ui-helper-reset, div.ui-helper-reset
	{mso-style-name:ui-helper-reset;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-helper-zfix, li.ui-helper-zfix, div.ui-helper-zfix
	{mso-style-name:ui-helper-zfix;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-widget-overlay, li.ui-widget-overlay, div.ui-widget-overlay
	{mso-style-name:ui-widget-overlay;
	margin-right:0in;
	margin-left:0in;
	background:#AAAAAA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-helper-clearfix, li.ui-helper-clearfix, div.ui-helper-clearfix
	{mso-style-name:ui-helper-clearfix;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon, li.ui-icon, div.ui-icon
	{mso-style-name:ui-icon;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-widget-content, li.ui-widget-content, div.ui-widget-content
	{mso-style-name:ui-widget-content;
	margin-right:0in;
	margin-left:0in;
	background:white;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#222222;}
p.ui-widget-header, li.ui-widget-header, div.ui-widget-header
	{mso-style-name:ui-widget-header;
	margin-right:0in;
	margin-left:0in;
	background:#CCCCCC;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#222222;
	font-weight:bold;}
p.ui-widget-shadow, li.ui-widget-shadow, div.ui-widget-shadow
	{mso-style-name:ui-widget-shadow;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:-6.0pt;
	margin-bottom:.0001pt;
	background:#AAAAAA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-widget, li.ui-widget, div.ui-widget
	{mso-style-name:ui-widget;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";}
p.ui-tabs, li.ui-tabs, div.ui-tabs
	{mso-style-name:ui-tabs;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-dialog, li.ui-dialog, div.ui-dialog
	{mso-style-name:ui-dialog;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";}
p.ui-dialog-titlebar, li.ui-dialog-titlebar, div.ui-dialog-titlebar
	{mso-style-name:ui-dialog-titlebar;
	margin-right:0in;
	margin-left:0in;
	background:#3E72A6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:white;}
p.ui-ncbiautocomplete-actions, li.ui-ncbiautocomplete-actions, div.ui-ncbiautocomplete-actions
	{mso-style-name:ui-ncbiautocomplete-actions;
	margin-top:.75pt;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	background:#CECECE;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbiautocomplete-link-pref, li.ui-ncbiautocomplete-link-pref, div.ui-ncbiautocomplete-link-pref
	{mso-style-name:ui-ncbiautocomplete-link-pref;
	margin-right:0in;
	margin-left:0in;
	text-indent:-945.65pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbibutton, li.ui-ncbibutton, div.ui-ncbibutton
	{mso-style-name:ui-ncbibutton;
	margin-right:1.2pt;
	margin-left:0in;
	text-align:center;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"inherit","serif";}
p.ui-button-icon-only, li.ui-button-icon-only, div.ui-button-icon-only
	{mso-style-name:ui-button-icon-only;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-icons-only, li.ui-button-icons-only, div.ui-button-icons-only
	{mso-style-name:ui-button-icons-only;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbigrid-outer-div, li.ui-ncbigrid-outer-div, div.ui-ncbigrid-outer-div
	{mso-style-name:ui-ncbigrid-outer-div;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:33.6pt;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbigrid-inner-div, li.ui-ncbigrid-inner-div, div.ui-ncbigrid-inner-div
	{mso-style-name:ui-ncbigrid-inner-div;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbigrid-filter-toolbar, li.ui-ncbigrid-filter-toolbar, div.ui-ncbigrid-filter-toolbar
	{mso-style-name:ui-ncbigrid-filter-toolbar;
	margin-right:0in;
	margin-left:0in;
	text-align:right;
	line-height:20.25pt;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbigrid-paged-toolbar, li.ui-ncbigrid-paged-toolbar, div.ui-ncbigrid-paged-toolbar
	{mso-style-name:ui-ncbigrid-paged-toolbar;
	margin-right:0in;
	margin-left:0in;
	line-height:19.4pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbigrid-checkbox-toolbar, li.ui-ncbigrid-checkbox-toolbar, div.ui-ncbigrid-checkbox-toolbar
	{mso-style-name:ui-ncbigrid-checkbox-toolbar;
	margin-right:0in;
	margin-left:0in;
	line-height:21.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbigrid-paged-countitems, li.ui-ncbigrid-paged-countitems, div.ui-ncbigrid-paged-countitems
	{mso-style-name:ui-ncbigrid-paged-countitems;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbigrid-paged-pagecontrol, li.ui-ncbigrid-paged-pagecontrol, div.ui-ncbigrid-paged-pagecontrol
	{mso-style-name:ui-ncbigrid-paged-pagecontrol;
	margin-top:0in;
	margin-right:0in;
	margin-left:0in;
	text-align:right;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbigrid-paged-toolbar-bottom, li.ui-ncbigrid-paged-toolbar-bottom, div.ui-ncbigrid-paged-toolbar-bottom
	{mso-style-name:ui-ncbigrid-paged-toolbar-bottom;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbigrid-select-question, li.ui-ncbigrid-select-question, div.ui-ncbigrid-select-question
	{mso-style-name:ui-ncbigrid-select-question;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	border:none;
	padding:0in;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";
	display:none;}
p.ui-ncbigrid-select-question-footer, li.ui-ncbigrid-select-question-footer, div.ui-ncbigrid-select-question-footer
	{mso-style-name:ui-ncbigrid-select-question-footer;
	margin-right:0in;
	margin-left:0in;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbibasicmenu, li.ui-ncbibasicmenu, div.ui-ncbibasicmenu
	{mso-style-name:ui-ncbibasicmenu;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbibasicmenuli, li.ui-ncbibasicmenuli, div.ui-ncbibasicmenuli
	{mso-style-name:ui-ncbibasicmenu>li;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.orientationhortli, li.orientationhortli, div.orientationhortli
	{mso-style-name:orientation_hort>li;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.jig-ncbimenu, li.jig-ncbimenu, div.jig-ncbimenu
	{mso-style-name:jig-ncbimenu;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.jig-ncbimenuli, li.jig-ncbimenuli, div.jig-ncbimenuli
	{mso-style-name:jig-ncbimenu>li;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbipopper-wrapper, li.ui-ncbipopper-wrapper, div.ui-ncbipopper-wrapper
	{mso-style-name:ui-ncbipopper-wrapper;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	display:none;}
p.ui-ncbipopper-basic, li.ui-ncbipopper-basic, div.ui-ncbipopper-basic
	{mso-style-name:ui-ncbipopper-basic;
	margin-right:0in;
	margin-left:0in;
	background:white;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#303030;}
p.brieflinkpopdesc, li.brieflinkpopdesc, div.brieflinkpopdesc
	{mso-style-name:brieflinkpopdesc;
	margin-top:4.8pt;
	margin-right:0in;
	margin-left:0in;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbitoggler-slave, li.ui-ncbitoggler-slave, div.ui-ncbitoggler-slave
	{mso-style-name:ui-ncbitoggler-slave;
	margin-top:2.4pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:12.0pt;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	display:none;}
p.ui-ncbitoggler-slave-open, li.ui-ncbitoggler-slave-open, div.ui-ncbitoggler-slave-open
	{mso-style-name:ui-ncbitoggler-slave-open;
	margin-top:2.4pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:12.0pt;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbilinksmenu, li.ui-ncbilinksmenu, div.ui-ncbilinksmenu
	{mso-style-name:ui-ncbilinksmenu;
	margin-right:0in;
	margin-left:0in;
	background:#FCFCFC;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#999999;
	font-weight:bold;}
p.ui-ncbilinksmenu-loadingmessage, li.ui-ncbilinksmenu-loadingmessage, div.ui-ncbilinksmenu-loadingmessage
	{mso-style-name:ui-ncbilinksmenu-loadingmessage;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbiclearbutton-wrap, li.ui-ncbiclearbutton-wrap, div.ui-ncbiclearbutton-wrap
	{mso-style-name:ui-ncbiclearbutton-wrap;
	margin-right:0in;
	margin-left:0in;
	background:white;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbiexpander, li.ui-ncbiexpander, div.ui-ncbiexpander
	{mso-style-name:ui-ncbiexpander;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbiexpander-simple, li.ui-ncbiexpander-simple, div.ui-ncbiexpander-simple
	{mso-style-name:ui-ncbiexpander-simple;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-expander-arrow-bar, li.ui-expander-arrow-bar, div.ui-expander-arrow-bar
	{mso-style-name:ui-expander-arrow-bar;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-expander-controllink, li.ui-expander-controllink, div.ui-expander-controllink
	{mso-style-name:ui-expander-controllink;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.jig-ncbiinpagenav-goto-container, li.jig-ncbiinpagenav-goto-container, div.jig-ncbiinpagenav-goto-container
	{mso-style-name:jig-ncbiinpagenav-goto-container;
	margin-right:0in;
	margin-left:0in;
	text-align:right;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbisetswitch, li.ui-ncbisetswitch, div.ui-ncbisetswitch
	{mso-style-name:ui-ncbisetswitch;
	margin-right:0in;
	margin-left:0in;
	background:#F6F6F6;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#444444;}
p.ui-ncbisetswitch-hasstar, li.ui-ncbisetswitch-hasstar, div.ui-ncbisetswitch-hasstar
	{mso-style-name:ui-ncbisetswitch-hasstar;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.fg-button-icon-left, li.fg-button-icon-left, div.fg-button-icon-left
	{mso-style-name:fg-button-icon-left;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.jig-ncbihistogram, li.jig-ncbihistogram, div.jig-ncbihistogram
	{mso-style-name:jig-ncbihistogram;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbihistogram, li.ui-ncbihistogram, div.ui-ncbihistogram
	{mso-style-name:ui-ncbihistogram;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbihistogram-display-area, li.ui-ncbihistogram-display-area, div.ui-ncbihistogram-display-area
	{mso-style-name:ui-ncbihistogram-display-area;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbihistogram-display-areaollih3, li.ui-ncbihistogram-display-areaollih3, div.ui-ncbihistogram-display-areaollih3
	{mso-style-name:ui-ncbihistogram-display-area>ol>li>h3;
	margin:0in;
	margin-bottom:.0001pt;
	text-indent:366.4pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbihistogram-controls, li.ui-ncbihistogram-controls, div.ui-ncbihistogram-controls
	{mso-style-name:ui-ncbihistogram-controls;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbihistogram-left, li.ui-ncbihistogram-left, div.ui-ncbihistogram-left
	{mso-style-name:ui-ncbihistogram-left;
	margin-right:0in;
	margin-left:2.25pt;
	text-align:center;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbihistogram-right, li.ui-ncbihistogram-right, div.ui-ncbihistogram-right
	{mso-style-name:ui-ncbihistogram-right;
	margin-right:2.25pt;
	margin-left:0in;
	text-align:center;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbihistogram-left-disabled, li.ui-ncbihistogram-left-disabled, div.ui-ncbihistogram-left-disabled
	{mso-style-name:ui-ncbihistogram-left-disabled;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#DDDDDD;}
p.ui-ncbihistogram-right-disabled, li.ui-ncbihistogram-right-disabled, div.ui-ncbihistogram-right-disabled
	{mso-style-name:ui-ncbihistogram-right-disabled;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#DDDDDD;}
p.ui-ncbihistogram-text, li.ui-ncbihistogram-text, div.ui-ncbihistogram-text
	{mso-style-name:ui-ncbihistogram-text;
	margin-top:0in;
	margin-right:12.75pt;
	margin-bottom:0in;
	margin-left:12.75pt;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:21.8pt;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbihistogram-tooltip, li.ui-ncbihistogram-tooltip, div.ui-ncbihistogram-tooltip
	{mso-style-name:ui-ncbihistogram-tooltip;
	margin-right:0in;
	margin-left:0in;
	background:white;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:black;
	display:none;}
p.ncbiactivevalidationmsg, li.ncbiactivevalidationmsg, div.ncbiactivevalidationmsg
	{mso-style-name:ncbiactivevalidation_msg;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ncbiactivevalidationmsgchecking, li.ncbiactivevalidationmsgchecking, div.ncbiactivevalidationmsgchecking
	{mso-style-name:ncbiactivevalidation_msg_checking;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#FF9900;}
p.ncbiactivevalidationmsgvalid, li.ncbiactivevalidationmsgvalid, div.ncbiactivevalidationmsgvalid
	{mso-style-name:ncbiactivevalidation_msg_valid;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:green;}
p.ncbiactivevalidationmsgerror, li.ncbiactivevalidationmsgerror, div.ncbiactivevalidationmsgerror
	{mso-style-name:ncbiactivevalidation_msg_error;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:red;}
p.ncbiactivevalidationmsginfo, li.ncbiactivevalidationmsginfo, div.ncbiactivevalidationmsginfo
	{mso-style-name:ncbiactivevalidation_msg_info;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:blue;}
p.ncbiactivevalidationelerror, li.ncbiactivevalidationelerror, div.ncbiactivevalidationelerror
	{mso-style-name:ncbiactivevalidation_el_error;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.social-buttons, li.social-buttons, div.social-buttons
	{mso-style-name:social-buttons;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.inlinelist, li.inlinelist, div.inlinelist
	{mso-style-name:inline_list;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.inline, li.inline, div.inline
	{mso-style-name:inline;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.fig, li.fig, div.fig
	{mso-style-name:fig;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.table, li.table, div.table
	{mso-style-name:table;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.pmc-wm, li.pmc-wm, div.pmc-wm
	{mso-style-name:pmc-wm;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.attic, li.attic, div.attic
	{mso-style-name:attic;
	margin-right:0in;
	margin-left:0in;
	background:#336699;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.basement, li.basement, div.basement
	{mso-style-name:basement;
	margin-right:0in;
	margin-left:0in;
	background:#336699;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.page-breadcrumbs, li.page-breadcrumbs, div.page-breadcrumbs
	{mso-style-name:page-breadcrumbs;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";}
p.first-line-outdent, li.first-line-outdent, div.first-line-outdent
	{mso-style-name:first-line-outdent;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.vatop, li.vatop, div.vatop
	{mso-style-name:va_top;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.vamiddle, li.vamiddle, div.vamiddle
	{mso-style-name:va_middle;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.qtrhythm, li.qtrhythm, div.qtrhythm
	{mso-style-name:qt_rhythm;
	margin-top:4.15pt;
	margin-right:0in;
	margin-bottom:4.15pt;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.notopmargin, li.notopmargin, div.notopmargin
	{mso-style-name:no_top_margin;
	margin-top:0in;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.nobottommargin, li.nobottommargin, div.nobottommargin
	{mso-style-name:no_bottom_margin;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.tscanvas, li.tscanvas, div.tscanvas
	{mso-style-name:ts_canvas;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.tsbar, li.tsbar, div.tsbar
	{mso-style-name:ts_bar;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	background:#DCF0F4;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.fm-reuse, li.fm-reuse, div.fm-reuse
	{mso-style-name:fm-reuse;
	margin-right:0in;
	margin-left:.5in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.fm-subtitle, li.fm-subtitle, div.fm-subtitle
	{mso-style-name:fm-subtitle;
	margin-top:0in;
	margin-right:0in;
	margin-left:0in;
	font-size:15.0pt;
	font-family:"Times New Roman","serif";}
p.fm-copyright-license, li.fm-copyright-license, div.fm-copyright-license
	{mso-style-name:fm-copyright-license;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.fm-citation-from, li.fm-citation-from, div.fm-citation-from
	{mso-style-name:fm-citation-from;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ft-thumb-box, li.ft-thumb-box, div.ft-thumb-box
	{mso-style-name:ft-thumb-box;
	margin:8.3pt;
	text-align:center;
	background:#F8F8F8;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ft-thumb-current, li.ft-thumb-current, div.ft-thumb-current
	{mso-style-name:ft-thumb-current;
	margin-right:0in;
	margin-left:0in;
	background:#D0DCE8;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.tab, li.tab, div.tab
	{mso-style-name:tab;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	background:#F8F8F8;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";}
p.arrowtab, li.arrowtab, div.arrowtab
	{mso-style-name:arrowtab;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	background:#F8F8F8;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";}
p.blanktab, li.blanktab, div.blanktab
	{mso-style-name:blanktab;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	background:#F8F8F8;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";}
p.thistab, li.thistab, div.thistab
	{mso-style-name:thistab;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	background:white;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;}
p.doi, li.doi, div.doi
	{mso-style-name:doi;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.msg-error, li.msg-error, div.msg-error
	{mso-style-name:msg-error;
	margin-right:0in;
	margin-left:0in;
	background:yellow;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:red;}
p.msg-warning, li.msg-warning, div.msg-warning
	{mso-style-name:msg-warning;
	margin-right:0in;
	margin-left:0in;
	background:yellow;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:brown;}
p.nihms-highlight, li.nihms-highlight, div.nihms-highlight
	{mso-style-name:nihms-highlight;
	margin-top:0in;
	margin-right:2.4pt;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:center;
	background:yellow;
	font-size:10.5pt;
	font-family:"Times New Roman","serif";
	color:#990000;}
p.head, li.head, div.head
	{mso-style-name:head;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.sub-head, li.sub-head, div.sub-head
	{mso-style-name:sub-head;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.headless, li.headless, div.headless
	{mso-style-name:headless;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.sub-navigation, li.sub-navigation, div.sub-navigation
	{mso-style-name:sub-navigation;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.sec, li.sec, div.sec
	{mso-style-name:sec;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.content-branding, li.content-branding, div.content-branding
	{mso-style-name:content-branding;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.banner-generic-logo-background, li.banner-generic-logo-background, div.banner-generic-logo-background
	{mso-style-name:banner-generic-logo-background;
	margin-right:0in;
	margin-left:0in;
	background:silver;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:white;}
p.banner-journal-name, li.banner-journal-name, div.banner-journal-name
	{mso-style-name:banner-journal-name;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	font-size:20.5pt;
	font-family:"Calibri","sans-serif";
	font-variant:small-caps;
	letter-spacing:.3pt;}
p.banner-journal-publisher-over-image, li.banner-journal-publisher-over-image, div.banner-journal-publisher-over-image
	{mso-style-name:banner-journal-publisher-over-image;
	margin-right:7.5pt;
	margin-left:63.0pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.banner-publisher-name, li.banner-publisher-name, div.banner-publisher-name
	{mso-style-name:banner-publisher-name;
	margin-right:0in;
	margin-left:0in;
	text-align:right;
	font-size:9.5pt;
	font-family:"Calibri","sans-serif";
	color:#AA1111;
	font-weight:bold;}
p.bl-w-jtitle-over, li.bl-w-jtitle-over, div.bl-w-jtitle-over
	{mso-style-name:bl-w-jtitle-over;
	margin-right:0in;
	margin-left:0in;
	font-size:18.0pt;
	font-family:"Times New Roman","serif";
	font-variant:small-caps;}
p.bl-w-jtitle-over-ph, li.bl-w-jtitle-over-ph, div.bl-w-jtitle-over-ph
	{mso-style-name:bl-w-jtitle-over-ph;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.bl-w-jtitle-over-ph-content, li.bl-w-jtitle-over-ph-content, div.bl-w-jtitle-over-ph-content
	{mso-style-name:bl-w-jtitle-over-ph-content;
	margin-top:3.0pt;
	margin-right:6.0pt;
	margin-bottom:3.0pt;
	margin-left:78.75pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.banner-journal-publisher-over-image-elsevierwt, li.banner-journal-publisher-over-image-elsevierwt, div.banner-journal-publisher-over-image-elsevierwt
	{mso-style-name:banner-journal-publisher-over-image-elsevierwt;
	margin-top:0in;
	margin-right:120.0pt;
	margin-bottom:0in;
	margin-left:15.0pt;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.elsevierwt-sponsored-label, li.elsevierwt-sponsored-label, div.elsevierwt-sponsored-label
	{mso-style-name:elsevierwt-sponsored-label;
	margin-right:0in;
	margin-left:-9.0pt;
	line-height:13.5pt;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	font-variant:small-caps;
	letter-spacing:.9pt;
	font-style:italic;}
p.bl-jtitle-sageopen, li.bl-jtitle-sageopen, div.bl-jtitle-sageopen
	{mso-style-name:bl-jtitle-sageopen;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#0055A5;}
p.bl-jtitle-iospressopenlib, li.bl-jtitle-iospressopenlib, div.bl-jtitle-iospressopenlib
	{mso-style-name:bl-jtitle-iospressopenlib;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:white;}
p.bl-jtitle-apasd, li.bl-jtitle-apasd, div.bl-jtitle-apasd
	{mso-style-name:bl-jtitle-apasd;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#1E73B3;}
p.bl-jtitle-springeropen, li.bl-jtitle-springeropen, div.bl-jtitle-springeropen
	{mso-style-name:bl-jtitle-springeropen;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#F0F0F0;}
p.bl-jtitle-sfesd, li.bl-jtitle-sfesd, div.bl-jtitle-sfesd
	{mso-style-name:bl-jtitle-sfesd;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:white;}
p.bl-jtitle-acssd, li.bl-jtitle-acssd, div.bl-jtitle-acssd
	{mso-style-name:bl-jtitle-acssd;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#1E73B3;}
p.bl-jtitle-esesd, li.bl-jtitle-esesd, div.bl-jtitle-esesd
	{mso-style-name:bl-jtitle-esesd;
	margin-right:0in;
	margin-left:0in;
	line-height:33.75pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.bl-jtitle-srfsd, li.bl-jtitle-srfsd, div.bl-jtitle-srfsd
	{mso-style-name:bl-jtitle-srfsd;
	margin-right:0in;
	margin-left:0in;
	line-height:33.75pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.bl-jtitle-tea, li.bl-jtitle-tea, div.bl-jtitle-tea
	{mso-style-name:bl-jtitle-tea;
	margin-right:0in;
	margin-left:0in;
	text-align:right;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#861316;}
p.bl-jtitle-rcpsychsd, li.bl-jtitle-rcpsychsd, div.bl-jtitle-rcpsychsd
	{mso-style-name:bl-jtitle-rcpsychsd;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#44448A;}
p.bl-jtitle-npgopen, li.bl-jtitle-npgopen, div.bl-jtitle-npgopen
	{mso-style-name:bl-jtitle-npgopen;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:white;}
p.bl-jtitle-maneyopen, li.bl-jtitle-maneyopen, div.bl-jtitle-maneyopen
	{mso-style-name:bl-jtitle-maneyopen;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:white;}
p.bl-jtitle-bmjgroup, li.bl-jtitle-bmjgroup, div.bl-jtitle-bmjgroup
	{mso-style-name:bl-jtitle-bmjgroup;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#003366;}
p.bl-jtitle-clpt, li.bl-jtitle-clpt, div.bl-jtitle-clpt
	{mso-style-name:bl-jtitle-clpt;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:white;}
p.bl-jtitle-nihpa-wiley, li.bl-jtitle-nihpa-wiley, div.bl-jtitle-nihpa-wiley
	{mso-style-name:bl-jtitle-nihpa-wiley;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:white;}
p.bl-jtitle-rsmsd, li.bl-jtitle-rsmsd, div.bl-jtitle-rsmsd
	{mso-style-name:bl-jtitle-rsmsd;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:white;}
p.bl-jtitle-hogrefesd, li.bl-jtitle-hogrefesd, div.bl-jtitle-hogrefesd
	{mso-style-name:bl-jtitle-hogrefesd;
	margin-right:0in;
	margin-left:0in;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#025490;}
p.mp-outer, li.mp-outer, div.mp-outer
	{mso-style-name:mp-outer;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.mp-outerdiv, li.mp-outerdiv, div.mp-outerdiv
	{mso-style-name:mp-outer>div;
	margin:1.5pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.toc-highlight1, li.toc-highlight1, div.toc-highlight1
	{mso-style-name:toc-highlight1;
	margin-right:0in;
	margin-left:0in;
	background:#FFFFD0;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.toc-highlight2, li.toc-highlight2, div.toc-highlight2
	{mso-style-name:toc-highlight2;
	margin-right:0in;
	margin-left:0in;
	background:#ACE4FF;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.toc-hl-inaugural, li.toc-hl-inaugural, div.toc-hl-inaugural
	{mso-style-name:toc-hl-inaugural;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#E64A00;}
p.courtesy-note, li.courtesy-note, div.courtesy-note
	{mso-style-name:courtesy-note;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";}
p.Footer1, li.Footer1, div.Footer1
	{mso-style-name:Footer1;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.suppmat, li.suppmat, div.suppmat
	{mso-style-name:suppmat;
	margin-top:8.3pt;
	margin-right:0in;
	margin-bottom:8.3pt;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.aligncenter, li.aligncenter, div.aligncenter
	{mso-style-name:align_center;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.mul-switcher, li.mul-switcher, div.mul-switcher
	{mso-style-name:mul-switcher;
	margin-right:0in;
	margin-left:0in;
	text-align:right;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.Strong1, li.Strong1, div.Strong1
	{mso-style-name:Strong1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	font-weight:bold;}
p.red, li.red, div.red
	{mso-style-name:red;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:red;}
p.navigator, li.navigator, div.navigator
	{mso-style-name:navigator;
	margin-top:15.0pt;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	background:#F6F6F6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.summary, li.summary, div.summary
	{mso-style-name:summary;
	margin-top:15.0pt;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.head1a, li.head1a, div.head1a
	{mso-style-name:head1a;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.navigator-header, li.navigator-header, div.navigator-header
	{mso-style-name:navigator-header;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.navigator-footer, li.navigator-footer, div.navigator-footer
	{mso-style-name:navigator-footer;
	margin-top:7.5pt;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.navigator-bar, li.navigator-bar, div.navigator-bar
	{mso-style-name:navigator-bar;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.navigator-page, li.navigator-page, div.navigator-page
	{mso-style-name:navigator-page;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.navigator-bar-table, li.navigator-bar-table, div.navigator-bar-table
	{mso-style-name:navigator-bar-table;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.section-with-images-on-the-same-page, li.section-with-images-on-the-same-page, div.section-with-images-on-the-same-page
	{mso-style-name:section-with-images-on-the-same-page;
	margin-top:15.0pt;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.main-archive-list-of-volumes, li.main-archive-list-of-volumes, div.main-archive-list-of-volumes
	{mso-style-name:main-archive-list-of-volumes;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.archive-header, li.archive-header, div.archive-header
	{mso-style-name:archive-header;
	margin-right:0in;
	margin-bottom:7.5pt;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	font-weight:bold;}
p.journal-block-title, li.journal-block-title, div.journal-block-title
	{mso-style-name:journal-block-title;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	background:#CCD8E4;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:black;
	font-weight:bold;}
p.vol-year-cell, li.vol-year-cell, div.vol-year-cell
	{mso-style-name:vol-year-cell;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	background:#CCD8E4;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:black;
	font-weight:bold;}
p.issue-block, li.issue-block, div.issue-block
	{mso-style-name:issue-block;
	margin-right:0in;
	margin-left:0in;
	background:#8CACCC;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.iss-dark-row, li.iss-dark-row, div.iss-dark-row
	{mso-style-name:iss-dark-row;
	margin-right:0in;
	margin-left:0in;
	background:#EFF1F3;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.iss-light-row, li.iss-light-row, div.iss-light-row
	{mso-style-name:iss-light-row;
	margin-right:0in;
	margin-left:0in;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.iss-cell, li.iss-cell, div.iss-cell
	{mso-style-name:iss-cell;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.vol-cell, li.vol-cell, div.vol-cell
	{mso-style-name:vol-cell;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.arc-issue, li.arc-issue, div.arc-issue
	{mso-style-name:arc-issue;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#0055AA;}
p.large-thumb-canvas, li.large-thumb-canvas, div.large-thumb-canvas
	{mso-style-name:large-thumb-canvas;
	margin:8.5pt;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#444444;
	display:none;}
p.co, li.co, div.co
	{mso-style-name:co;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	display:none;}
p.co-default, li.co-default, div.co-default
	{mso-style-name:co-default;
	margin:8.5pt;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#444444;}
p.large-thumb-canvas-1, li.large-thumb-canvas-1, div.large-thumb-canvas-1
	{mso-style-name:large-thumb-canvas-1;
	margin-right:0in;
	margin-left:0in;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.co-inner, li.co-inner, div.co-inner
	{mso-style-name:co-inner;
	margin-right:0in;
	margin-left:0in;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.in-progress, li.in-progress, div.in-progress
	{mso-style-name:in-progress;
	margin:1.5pt;
	background:#444444;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.large-thumb, li.large-thumb, div.large-thumb
	{mso-style-name:large-thumb;
	margin:1.5pt;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	display:none;}
p.small-thumb-canvas, li.small-thumb-canvas, div.small-thumb-canvas
	{mso-style-name:small-thumb-canvas;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.small-thumb, li.small-thumb, div.small-thumb
	{mso-style-name:small-thumb;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.figpopup-sensitive-area, li.figpopup-sensitive-area, div.figpopup-sensitive-area
	{mso-style-name:figpopup-sensitive-area;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.print-view, li.print-view, div.print-view
	{mso-style-name:print-view;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.citationexporter-header, li.citationexporter-header, div.citationexporter-header
	{mso-style-name:citationexporter-header;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	font-style:italic;}
p.citationexporter-footer, li.citationexporter-footer, div.citationexporter-footer
	{mso-style-name:citationexporter-footer;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.mathjaxpreview, li.mathjaxpreview, div.mathjaxpreview
	{mso-style-name:mathjax_preview;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#888888;}
p.mathjaxerror, li.mathjaxerror, div.mathjaxerror
	{mso-style-name:mathjax_error;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#CC0000;
	font-style:italic;}
p.mathjaxmenu, li.mathjaxmenu, div.mathjaxmenu
	{mso-style-name:mathjax_menu;
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:black;}
p.mathjaxmenuitem, li.mathjaxmenuitem, div.mathjaxmenuitem
	{mso-style-name:mathjax_menuitem;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.mathjaxmenuarrow, li.mathjaxmenuarrow, div.mathjaxmenuarrow
	{mso-style-name:mathjax_menuarrow;
	margin-right:0in;
	margin-left:0in;
	font-size:9.0pt;
	font-family:"Arial Unicode MS","serif";
	color:#666666;}
p.mathjaxmenucheck, li.mathjaxmenucheck, div.mathjaxmenucheck
	{mso-style-name:mathjax_menucheck;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Arial Unicode MS","serif";}
p.mathjaxmenulabel, li.mathjaxmenulabel, div.mathjaxmenulabel
	{mso-style-name:mathjax_menulabel;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	font-style:italic;}
p.mathjaxmenurule, li.mathjaxmenurule, div.mathjaxmenurule
	{mso-style-name:mathjax_menurule;
	margin-top:3.0pt;
	margin-right:.75pt;
	margin-bottom:0in;
	margin-left:.75pt;
	margin-bottom:.0001pt;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.mathjaxmenuclose, li.mathjaxmenuclose, div.mathjaxmenuclose
	{mso-style-name:mathjax_menuclose;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:18.0pt;
	font-family:"Courier New";
	color:#F0F0F0;}
p.print-log, li.print-log, div.print-log
	{mso-style-name:print-log;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-accordion-header, li.ui-accordion-header, div.ui-accordion-header
	{mso-style-name:ui-accordion-header;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-accordion-icons, li.ui-accordion-icons, div.ui-accordion-icons
	{mso-style-name:ui-accordion-icons;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-accordion-content, li.ui-accordion-content, div.ui-accordion-content
	{mso-style-name:ui-accordion-content;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-text, li.ui-button-text, div.ui-button-text
	{mso-style-name:ui-button-text;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-header, li.ui-datepicker-header, div.ui-datepicker-header
	{mso-style-name:ui-datepicker-header;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-next, li.ui-datepicker-next, div.ui-datepicker-next
	{mso-style-name:ui-datepicker-next;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-prev, li.ui-datepicker-prev, div.ui-datepicker-prev
	{mso-style-name:ui-datepicker-prev;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-title, li.ui-datepicker-title, div.ui-datepicker-title
	{mso-style-name:ui-datepicker-title;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-buttonpane, li.ui-datepicker-buttonpane, div.ui-datepicker-buttonpane
	{mso-style-name:ui-datepicker-buttonpane;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-group, li.ui-datepicker-group, div.ui-datepicker-group
	{mso-style-name:ui-datepicker-group;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-dialog-title, li.ui-dialog-title, div.ui-dialog-title
	{mso-style-name:ui-dialog-title;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-dialog-buttonpane, li.ui-dialog-buttonpane, div.ui-dialog-buttonpane
	{mso-style-name:ui-dialog-buttonpane;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-menu-item, li.ui-menu-item, div.ui-menu-item
	{mso-style-name:ui-menu-item;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-menu-divider, li.ui-menu-divider, div.ui-menu-divider
	{mso-style-name:ui-menu-divider;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-progressbar-value, li.ui-progressbar-value, div.ui-progressbar-value
	{mso-style-name:ui-progressbar-value;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-progressbar-overlay, li.ui-progressbar-overlay, div.ui-progressbar-overlay
	{mso-style-name:ui-progressbar-overlay;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-slider-handle, li.ui-slider-handle, div.ui-slider-handle
	{mso-style-name:ui-slider-handle;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-slider-range, li.ui-slider-range, div.ui-slider-range
	{mso-style-name:ui-slider-range;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-tabs-nav, li.ui-tabs-nav, div.ui-tabs-nav
	{mso-style-name:ui-tabs-nav;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-tabs-panel, li.ui-tabs-panel, div.ui-tabs-panel
	{mso-style-name:ui-tabs-panel;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-tabs-hide, li.ui-tabs-hide, div.ui-tabs-hide
	{mso-style-name:ui-tabs-hide;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-dialog-titlebar-close, li.ui-dialog-titlebar-close, div.ui-dialog-titlebar-close
	{mso-style-name:ui-dialog-titlebar-close;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-dialog-content, li.ui-dialog-content, div.ui-dialog-content
	{mso-style-name:ui-dialog-content;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbiautocomplete-link-pref-right, li.ui-ncbiautocomplete-link-pref-right, div.ui-ncbiautocomplete-link-pref-right
	{mso-style-name:ui-ncbiautocomplete-link-pref-right;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-icon-primary, li.ui-button-icon-primary, div.ui-button-icon-primary
	{mso-style-name:ui-button-icon-primary;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-icon-secondary, li.ui-button-icon-secondary, div.ui-button-icon-secondary
	{mso-style-name:ui-button-icon-secondary;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.prev, li.prev, div.prev
	{mso-style-name:prev;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.next, li.next, div.next
	{mso-style-name:next;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbigrid-select-row-count, li.ui-ncbigrid-select-row-count, div.ui-ncbigrid-select-row-count
	{mso-style-name:ui-ncbigrid-select-row-count;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbibasicmenulia, li.ui-ncbibasicmenulia, div.ui-ncbibasicmenulia
	{mso-style-name:ui-ncbibasicmenu>li>a;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbimenu-item-leaf, li.ui-ncbimenu-item-leaf, div.ui-ncbimenu-item-leaf
	{mso-style-name:ui-ncbimenu-item-leaf;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.brieflinkpop, li.brieflinkpop, div.brieflinkpop
	{mso-style-name:brieflinkpop;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.star, li.star, div.star
	{mso-style-name:star;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.jig-ncbisetswitch, li.jig-ncbisetswitch, div.jig-ncbisetswitch
	{mso-style-name:jig-ncbisetswitch;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbisetswitch-button, li.ui-ncbisetswitch-button, div.ui-ncbisetswitch-button
	{mso-style-name:ui-ncbisetswitch-button;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbisetswitch-options, li.ui-ncbisetswitch-options, div.ui-ncbisetswitch-options
	{mso-style-name:ui-ncbisetswitch-options;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.boxed-text-box, li.boxed-text-box, div.boxed-text-box
	{mso-style-name:boxed-text-box;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.cell-from, li.cell-from, div.cell-from
	{mso-style-name:cell-from;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.cell-citation, li.cell-citation, div.cell-citation
	{mso-style-name:cell-citation;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.figpopup, li.figpopup, div.figpopup
	{mso-style-name:figpopup;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.button, li.button, div.button
	{mso-style-name:button;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.retraction, li.retraction, div.retraction
	{mso-style-name:retraction;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.mathjaxhoverarrow, li.mathjaxhoverarrow, div.mathjaxhoverarrow
	{mso-style-name:mathjax_hover_arrow;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.pbody, li.pbody, div.pbody
	{mso-style-name:pbody;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.page-box, li.page-box, div.page-box
	{mso-style-name:page-box;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.page-box-wide, li.page-box-wide, div.page-box-wide
	{mso-style-name:page-box-wide;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.nomaxwidth, li.nomaxwidth, div.nomaxwidth
	{mso-style-name:no_max_width;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.f, li.f, div.f
	{mso-style-name:f;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.l, li.l, div.l
	{mso-style-name:l;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-accordion-header-icon, li.ui-accordion-header-icon, div.ui-accordion-header-icon
	{mso-style-name:ui-accordion-header-icon;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-selectmenu-optgroup, li.ui-selectmenu-optgroup, div.ui-selectmenu-optgroup
	{mso-style-name:ui-selectmenu-optgroup;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-tabs-anchor, li.ui-tabs-anchor, div.ui-tabs-anchor
	{mso-style-name:ui-tabs-anchor;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbibutton-submit, li.ui-ncbibutton-submit, div.ui-ncbibutton-submit
	{mso-style-name:ui-ncbibutton-submit;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbibutton-cancel, li.ui-ncbibutton-cancel, div.ui-ncbibutton-cancel
	{mso-style-name:ui-ncbibutton-cancel;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ltd-hover, li.ltd-hover, div.ltd-hover
	{mso-style-name:ltd-hover;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.warn, li.warn, div.warn
	{mso-style-name:warn;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.notice, li.notice, div.notice
	{mso-style-name:notice;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.content, li.content, div.content
	{mso-style-name:content;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.onelinesource, li.onelinesource, div.onelinesource
	{mso-style-name:one_line_source;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.tertiary, li.tertiary, div.tertiary
	{mso-style-name:tertiary;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.mathjaxhoverframe, li.mathjaxhoverframe, div.mathjaxhoverframe
	{mso-style-name:mathjax_hover_frame;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
span.other-issues
	{mso-style-name:other-issues;}
span.underline
	{mso-style-name:underline;}
span.double-underline
	{mso-style-name:double-underline;}
span.bold-double-underline
	{mso-style-name:bold-double-underline;}
span.ui-icon1
	{mso-style-name:ui-icon1;
	display:none;}
span.ui-selectmenu-text
	{mso-style-name:ui-selectmenu-text;}
span.pagelink
	{mso-style-name:page_link;}
span.ui-icon-plus-minus-big
	{mso-style-name:ui-icon-plus-minus-big;}
span.ui-icon-plus-minus-big-open
	{mso-style-name:ui-icon-plus-minus-big-open;}
span.collapsabletbodyicon
	{mso-style-name:collapsabletbodyicon;}
p.ui-accordion-header1, li.ui-accordion-header1, div.ui-accordion-header1
	{mso-style-name:ui-accordion-header1;
	margin-top:1.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-accordion-icons1, li.ui-accordion-icons1, div.ui-accordion-icons1
	{mso-style-name:ui-accordion-icons1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-accordion-icons2, li.ui-accordion-icons2, div.ui-accordion-icons2
	{mso-style-name:ui-accordion-icons2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-accordion-header-icon1, li.ui-accordion-header-icon1, div.ui-accordion-header-icon1
	{mso-style-name:ui-accordion-header-icon1;
	margin-top:0in;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-accordion-content1, li.ui-accordion-content1, div.ui-accordion-content1
	{mso-style-name:ui-accordion-content1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-text1, li.ui-button-text1, div.ui-button-text1
	{mso-style-name:ui-button-text1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-text2, li.ui-button-text2, div.ui-button-text2
	{mso-style-name:ui-button-text2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-text3, li.ui-button-text3, div.ui-button-text3
	{mso-style-name:ui-button-text3;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon2, li.ui-icon2, div.ui-icon2
	{mso-style-name:ui-icon2;
	margin-top:0in;
	margin-right:0in;
	margin-left:-6.0pt;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button1, li.ui-button1, div.ui-button1
	{mso-style-name:ui-button1;
	margin-right:-.05in;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-header1, li.ui-datepicker-header1, div.ui-datepicker-header1
	{mso-style-name:ui-datepicker-header1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-next1, li.ui-datepicker-next1, div.ui-datepicker-next1
	{mso-style-name:ui-datepicker-next1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-prev1, li.ui-datepicker-prev1, div.ui-datepicker-prev1
	{mso-style-name:ui-datepicker-prev1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-title1, li.ui-datepicker-title1, div.ui-datepicker-title1
	{mso-style-name:ui-datepicker-title1;
	margin-top:0in;
	margin-right:27.6pt;
	margin-bottom:0in;
	margin-left:27.6pt;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:21.6pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-buttonpane1, li.ui-datepicker-buttonpane1, div.ui-datepicker-buttonpane1
	{mso-style-name:ui-datepicker-buttonpane1;
	margin-top:8.4pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-group1, li.ui-datepicker-group1, div.ui-datepicker-group1
	{mso-style-name:ui-datepicker-group1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-group2, li.ui-datepicker-group2, div.ui-datepicker-group2
	{mso-style-name:ui-datepicker-group2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-group3, li.ui-datepicker-group3, div.ui-datepicker-group3
	{mso-style-name:ui-datepicker-group3;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-header2, li.ui-datepicker-header2, div.ui-datepicker-header2
	{mso-style-name:ui-datepicker-header2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-header3, li.ui-datepicker-header3, div.ui-datepicker-header3
	{mso-style-name:ui-datepicker-header3;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-buttonpane2, li.ui-datepicker-buttonpane2, div.ui-datepicker-buttonpane2
	{mso-style-name:ui-datepicker-buttonpane2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-buttonpane3, li.ui-datepicker-buttonpane3, div.ui-datepicker-buttonpane3
	{mso-style-name:ui-datepicker-buttonpane3;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-header4, li.ui-datepicker-header4, div.ui-datepicker-header4
	{mso-style-name:ui-datepicker-header4;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-datepicker-header5, li.ui-datepicker-header5, div.ui-datepicker-header5
	{mso-style-name:ui-datepicker-header5;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-dialog-title1, li.ui-dialog-title1, div.ui-dialog-title1
	{mso-style-name:ui-dialog-title1;
	margin-top:1.2pt;
	margin-right:12.0pt;
	margin-bottom:2.4pt;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-dialog-buttonpane1, li.ui-dialog-buttonpane1, div.ui-dialog-buttonpane1
	{mso-style-name:ui-dialog-buttonpane1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-left:0in;
	background:whitesmoke;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-menu-item1, li.ui-menu-item1, div.ui-menu-item1
	{mso-style-name:ui-menu-item1;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-menu-divider1, li.ui-menu-divider1, div.ui-menu-divider1
	{mso-style-name:ui-menu-divider1;
	margin-top:3.75pt;
	margin-right:0in;
	margin-bottom:3.75pt;
	margin-left:0in;
	line-height:0%;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";}
p.ui-state-active1, li.ui-state-active1, div.ui-state-active1
	{mso-style-name:ui-state-active1;
	margin-top:0in;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	background:white;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#212121;}
p.ui-state-focus1, li.ui-state-focus1, div.ui-state-focus1
	{mso-style-name:ui-state-focus1;
	margin-top:0in;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	background:#DADADA;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#212121;}
p.ui-menu-item2, li.ui-menu-item2, div.ui-menu-item2
	{mso-style-name:ui-menu-item2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon3, li.ui-icon3, div.ui-icon3
	{mso-style-name:ui-icon3;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-progressbar-value1, li.ui-progressbar-value1, div.ui-progressbar-value1
	{mso-style-name:ui-progressbar-value1;
	margin-top:0in;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-progressbar-overlay1, li.ui-progressbar-overlay1, div.ui-progressbar-overlay1
	{mso-style-name:ui-progressbar-overlay1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-progressbar-value2, li.ui-progressbar-value2, div.ui-progressbar-value2
	{mso-style-name:ui-progressbar-value2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-resizable-handle1, li.ui-resizable-handle1, div.ui-resizable-handle1
	{mso-style-name:ui-resizable-handle1;
	margin-right:0in;
	margin-left:0in;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	display:none;}
p.ui-resizable-handle2, li.ui-resizable-handle2, div.ui-resizable-handle2
	{mso-style-name:ui-resizable-handle2;
	margin-right:0in;
	margin-left:0in;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	display:none;}
p.ui-menu1, li.ui-menu1, div.ui-menu1
	{mso-style-name:ui-menu1;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-selectmenu-optgroup1, li.ui-selectmenu-optgroup1, div.ui-selectmenu-optgroup1
	{mso-style-name:ui-selectmenu-optgroup1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	font-weight:bold;}
span.ui-icon4
	{mso-style-name:ui-icon4;
	display:none;}
span.ui-selectmenu-text1
	{mso-style-name:ui-selectmenu-text1;
	display:none;}
p.ui-slider-handle1, li.ui-slider-handle1, div.ui-slider-handle1
	{mso-style-name:ui-slider-handle1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-slider-range1, li.ui-slider-range1, div.ui-slider-range1
	{mso-style-name:ui-slider-range1;
	margin-right:0in;
	margin-left:0in;
	font-size:8.5pt;
	font-family:"Times New Roman","serif";}
p.ui-slider-handle2, li.ui-slider-handle2, div.ui-slider-handle2
	{mso-style-name:ui-slider-handle2;
	margin-right:0in;
	margin-left:-.1in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-slider-handle3, li.ui-slider-handle3, div.ui-slider-handle3
	{mso-style-name:ui-slider-handle3;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-slider-range2, li.ui-slider-range2, div.ui-slider-range2
	{mso-style-name:ui-slider-range2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon5, li.ui-icon5, div.ui-icon5
	{mso-style-name:ui-icon5;
	margin-top:0in;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-tabs-anchor1, li.ui-tabs-anchor1, div.ui-tabs-anchor1
	{mso-style-name:ui-tabs-anchor1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-tooltip1, li.ui-tooltip1, div.ui-tooltip1
	{mso-style-name:ui-tooltip1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-widget1, li.ui-widget1, div.ui-widget1
	{mso-style-name:ui-widget1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";}
p.ui-state-default1, li.ui-state-default1, div.ui-state-default1
	{mso-style-name:ui-state-default1;
	margin-right:0in;
	margin-left:0in;
	background:#E6E6E6;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#555555;}
p.ui-state-default2, li.ui-state-default2, div.ui-state-default2
	{mso-style-name:ui-state-default2;
	margin-right:0in;
	margin-left:0in;
	background:#E6E6E6;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#555555;}
p.ui-state-focus2, li.ui-state-focus2, div.ui-state-focus2
	{mso-style-name:ui-state-focus2;
	margin-right:0in;
	margin-left:0in;
	background:#DADADA;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#212121;}
p.ui-state-hover1, li.ui-state-hover1, div.ui-state-hover1
	{mso-style-name:ui-state-hover1;
	margin-right:0in;
	margin-left:0in;
	background:#DADADA;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#212121;}
p.ui-state-focus3, li.ui-state-focus3, div.ui-state-focus3
	{mso-style-name:ui-state-focus3;
	margin-right:0in;
	margin-left:0in;
	background:#DADADA;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#212121;}
p.ui-state-hover2, li.ui-state-hover2, div.ui-state-hover2
	{mso-style-name:ui-state-hover2;
	margin-right:0in;
	margin-left:0in;
	background:#DADADA;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#212121;}
p.ui-state-active2, li.ui-state-active2, div.ui-state-active2
	{mso-style-name:ui-state-active2;
	margin-right:0in;
	margin-left:0in;
	background:white;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#212121;}
p.ui-state-active3, li.ui-state-active3, div.ui-state-active3
	{mso-style-name:ui-state-active3;
	margin-right:0in;
	margin-left:0in;
	background:white;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#212121;}
p.ui-state-highlight1, li.ui-state-highlight1, div.ui-state-highlight1
	{mso-style-name:ui-state-highlight1;
	margin-right:0in;
	margin-left:0in;
	background:#FBF9EE;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#363636;}
p.ui-state-highlight2, li.ui-state-highlight2, div.ui-state-highlight2
	{mso-style-name:ui-state-highlight2;
	margin-right:0in;
	margin-left:0in;
	background:#FBF9EE;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#363636;}
p.ui-state-error1, li.ui-state-error1, div.ui-state-error1
	{mso-style-name:ui-state-error1;
	margin-right:0in;
	margin-left:0in;
	background:#FEF1EC;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#CD0A0A;}
p.ui-state-error2, li.ui-state-error2, div.ui-state-error2
	{mso-style-name:ui-state-error2;
	margin-right:0in;
	margin-left:0in;
	background:#FEF1EC;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#CD0A0A;}
p.ui-state-error-text1, li.ui-state-error-text1, div.ui-state-error-text1
	{mso-style-name:ui-state-error-text1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#CD0A0A;}
p.ui-state-error-text2, li.ui-state-error-text2, div.ui-state-error-text2
	{mso-style-name:ui-state-error-text2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#CD0A0A;}
p.ui-priority-primary1, li.ui-priority-primary1, div.ui-priority-primary1
	{mso-style-name:ui-priority-primary1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	font-weight:bold;}
p.ui-priority-primary2, li.ui-priority-primary2, div.ui-priority-primary2
	{mso-style-name:ui-priority-primary2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	font-weight:bold;}
p.ui-priority-secondary1, li.ui-priority-secondary1, div.ui-priority-secondary1
	{mso-style-name:ui-priority-secondary1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-priority-secondary2, li.ui-priority-secondary2, div.ui-priority-secondary2
	{mso-style-name:ui-priority-secondary2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-state-disabled1, li.ui-state-disabled1, div.ui-state-disabled1
	{mso-style-name:ui-state-disabled1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-state-disabled2, li.ui-state-disabled2, div.ui-state-disabled2
	{mso-style-name:ui-state-disabled2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon6, li.ui-icon6, div.ui-icon6
	{mso-style-name:ui-icon6;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon7, li.ui-icon7, div.ui-icon7
	{mso-style-name:ui-icon7;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon8, li.ui-icon8, div.ui-icon8
	{mso-style-name:ui-icon8;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon9, li.ui-icon9, div.ui-icon9
	{mso-style-name:ui-icon9;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon10, li.ui-icon10, div.ui-icon10
	{mso-style-name:ui-icon10;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon11, li.ui-icon11, div.ui-icon11
	{mso-style-name:ui-icon11;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon12, li.ui-icon12, div.ui-icon12
	{mso-style-name:ui-icon12;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon13, li.ui-icon13, div.ui-icon13
	{mso-style-name:ui-icon13;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon14, li.ui-icon14, div.ui-icon14
	{mso-style-name:ui-icon14;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-tabs-nav1, li.ui-tabs-nav1, div.ui-tabs-nav1
	{mso-style-name:ui-tabs-nav1;
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.tertiary1, li.tertiary1, div.tertiary1
	{mso-style-name:tertiary1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#666666;}
p.tertiary2, li.tertiary2, div.tertiary2
	{mso-style-name:tertiary2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#985735;}
p.ui-tabs-panel1, li.ui-tabs-panel1, div.ui-tabs-panel1
	{mso-style-name:ui-tabs-panel1;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-tabs-hide1, li.ui-tabs-hide1, div.ui-tabs-hide1
	{mso-style-name:ui-tabs-hide1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	display:none;}
p.ui-dialog-titlebar1, li.ui-dialog-titlebar1, div.ui-dialog-titlebar1
	{mso-style-name:ui-dialog-titlebar1;
	margin-right:0in;
	margin-left:0in;
	background:#3E72A6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:white;}
p.ui-dialog-titlebar-close1, li.ui-dialog-titlebar-close1, div.ui-dialog-titlebar-close1
	{mso-style-name:ui-dialog-titlebar-close1;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-dialog-content1, li.ui-dialog-content1, div.ui-dialog-content1
	{mso-style-name:ui-dialog-content1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-resizable-se1, li.ui-resizable-se1, div.ui-resizable-se1
	{mso-style-name:ui-resizable-se1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon15, li.ui-icon15, div.ui-icon15
	{mso-style-name:ui-icon15;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-state-hover3, li.ui-state-hover3, div.ui-state-hover3
	{mso-style-name:ui-state-hover3;
	margin-right:0in;
	margin-left:0in;
	background:#DADADA;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#212121;}
p.ui-ncbibutton-submit1, li.ui-ncbibutton-submit1, div.ui-ncbibutton-submit1
	{mso-style-name:ui-ncbibutton-submit1;
	margin-right:6.55pt;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbibutton-cancel1, li.ui-ncbibutton-cancel1, div.ui-ncbibutton-cancel1
	{mso-style-name:ui-ncbibutton-cancel1;
	margin-right:0in;
	margin-left:0in;
	line-height:22.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#2F4A8B;}
p.ui-button-text4, li.ui-button-text4, div.ui-button-text4
	{mso-style-name:ui-button-text4;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbiautocomplete-link-pref-right1, li.ui-ncbiautocomplete-link-pref-right1, div.ui-ncbiautocomplete-link-pref-right1
	{mso-style-name:ui-ncbiautocomplete-link-pref-right1;
	margin-right:0in;
	margin-left:0in;
	text-align:right;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-text5, li.ui-button-text5, div.ui-button-text5
	{mso-style-name:ui-button-text5;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-text6, li.ui-button-text6, div.ui-button-text6
	{mso-style-name:ui-button-text6;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-text7, li.ui-button-text7, div.ui-button-text7
	{mso-style-name:ui-button-text7;
	margin-right:0in;
	margin-left:0in;
	text-indent:595.95pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-text8, li.ui-button-text8, div.ui-button-text8
	{mso-style-name:ui-button-text8;
	margin-right:0in;
	margin-left:0in;
	text-indent:595.95pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-text9, li.ui-button-text9, div.ui-button-text9
	{mso-style-name:ui-button-text9;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-text10, li.ui-button-text10, div.ui-button-text10
	{mso-style-name:ui-button-text10;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon16, li.ui-icon16, div.ui-icon16
	{mso-style-name:ui-icon16;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon17, li.ui-icon17, div.ui-icon17
	{mso-style-name:ui-icon17;
	margin-top:0in;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon18, li.ui-icon18, div.ui-icon18
	{mso-style-name:ui-icon18;
	margin-top:0in;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon19, li.ui-icon19, div.ui-icon19
	{mso-style-name:ui-icon19;
	margin-top:0in;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon20, li.ui-icon20, div.ui-icon20
	{mso-style-name:ui-icon20;
	margin-top:0in;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon21, li.ui-icon21, div.ui-icon21
	{mso-style-name:ui-icon21;
	margin-top:0in;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-icon-primary1, li.ui-button-icon-primary1, div.ui-button-icon-primary1
	{mso-style-name:ui-button-icon-primary1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-icon-primary2, li.ui-button-icon-primary2, div.ui-button-icon-primary2
	{mso-style-name:ui-button-icon-primary2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-icon-primary3, li.ui-button-icon-primary3, div.ui-button-icon-primary3
	{mso-style-name:ui-button-icon-primary3;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-icon-secondary1, li.ui-button-icon-secondary1, div.ui-button-icon-secondary1
	{mso-style-name:ui-button-icon-secondary1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-button-icon-secondary2, li.ui-button-icon-secondary2, div.ui-button-icon-secondary2
	{mso-style-name:ui-button-icon-secondary2;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbigrid-paged-pagecontrol1, li.ui-ncbigrid-paged-pagecontrol1, div.ui-ncbigrid-paged-pagecontrol1
	{mso-style-name:ui-ncbigrid-paged-pagecontrol1;
	margin-top:0in;
	margin-right:0in;
	margin-left:0in;
	text-align:right;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";}
p.prev1, li.prev1, div.prev1
	{mso-style-name:prev1;
	margin-right:.1in;
	margin-left:2.4pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.next1, li.next1, div.next1
	{mso-style-name:next1;
	margin-right:2.4pt;
	margin-left:.1in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbigrid-select-row-count1, li.ui-ncbigrid-select-row-count1, div.ui-ncbigrid-select-row-count1
	{mso-style-name:ui-ncbigrid-select-row-count1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	font-weight:bold;}
span.pagelink1
	{mso-style-name:page_link1;
	color:#CCCCCC;}
span.collapsabletbodyicon1
	{mso-style-name:collapsabletbodyicon1;}
span.ui-icon-plus-minus-big1
	{mso-style-name:ui-icon-plus-minus-big1;}
span.ui-icon-plus-minus-big-open1
	{mso-style-name:ui-icon-plus-minus-big-open1;}
p.ui-ncbigrid-outer-div1, li.ui-ncbigrid-outer-div1, div.ui-ncbigrid-outer-div1
	{mso-style-name:ui-ncbigrid-outer-div1;
	margin:0in;
	margin-bottom:.0001pt;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbimenu-item-leaf1, li.ui-ncbimenu-item-leaf1, div.ui-ncbimenu-item-leaf1
	{mso-style-name:ui-ncbimenu-item-leaf1;
	margin-top:0in;
	margin-right:9.0pt;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.brieflinkpop1, li.brieflinkpop1, div.brieflinkpop1
	{mso-style-name:brieflinkpop1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
span.ui-icon-plus-minus-big2
	{mso-style-name:ui-icon-plus-minus-big2;}
span.ui-icon-plus-minus-big-open2
	{mso-style-name:ui-icon-plus-minus-big-open2;}
span.ui-icon22
	{mso-style-name:ui-icon22;
	display:none;}
span.ui-icon23
	{mso-style-name:ui-icon23;
	display:none;}
p.star1, li.star1, div.star1
	{mso-style-name:star1;
	margin-right:7.4pt;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.jig-ncbisetswitch1, li.jig-ncbisetswitch1, div.jig-ncbisetswitch1
	{mso-style-name:jig-ncbisetswitch1;
	margin-right:0in;
	margin-left:0in;
	line-height:14.75pt;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#333333;}
p.ui-ncbisetswitch-button1, li.ui-ncbisetswitch-button1, div.ui-ncbisetswitch-button1
	{mso-style-name:ui-ncbisetswitch-button1;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon24, li.ui-icon24, div.ui-icon24
	{mso-style-name:ui-icon24;
	margin:5.55pt;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ltd-hover1, li.ltd-hover1, div.ltd-hover1
	{mso-style-name:ltd-hover1;
	margin-right:0in;
	margin-left:0in;
	background:#E8E8E8;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-icon25, li.ui-icon25, div.ui-icon25
	{mso-style-name:ui-icon25;
	margin-right:0in;
	margin-left:0in;
	text-indent:367.15pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.ui-ncbisetswitch-options1, li.ui-ncbisetswitch-options1, div.ui-ncbisetswitch-options1
	{mso-style-name:ui-ncbisetswitch-options1;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.pbody1, li.pbody1, div.pbody1
	{mso-style-name:pbody1;
	margin-top:0in;
	margin-right:16.6pt;
	margin-bottom:0in;
	margin-left:16.6pt;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.page-box1, li.page-box1, div.page-box1
	{mso-style-name:page-box1;
	margin-top:16.6pt;
	margin-right:0in;
	margin-bottom:16.6pt;
	margin-left:0in;
	background:#F8F8F8;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.page-box-wide1, li.page-box-wide1, div.page-box-wide1
	{mso-style-name:page-box-wide1;
	margin-top:16.6pt;
	margin-right:0in;
	margin-bottom:16.6pt;
	margin-left:0in;
	background:#F8F8F8;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.nomaxwidth1, li.nomaxwidth1, div.nomaxwidth1
	{mso-style-name:no_max_width1;
	margin-right:0in;
	margin-left:0in;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.content1, li.content1, div.content1
	{mso-style-name:content1;
	margin:16.6pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.boxed-text-box1, li.boxed-text-box1, div.boxed-text-box1
	{mso-style-name:boxed-text-box1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.f1, li.f1, div.f1
	{mso-style-name:f1;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.l1, li.l1, div.l1
	{mso-style-name:l1;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.cell-from1, li.cell-from1, div.cell-from1
	{mso-style-name:cell-from1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	font-weight:bold;}
p.cell-citation1, li.cell-citation1, div.cell-citation1
	{mso-style-name:cell-citation1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.figpopup1, li.figpopup1, div.figpopup1
	{mso-style-name:figpopup1;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.button1, li.button1, div.button1
	{mso-style-name:button1;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	background:white;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	color:#336699;}
p.retraction1, li.retraction1, div.retraction1
	{mso-style-name:retraction1;
	margin-right:0in;
	margin-left:0in;
	background:red;
	font-size:12.0pt;
	font-family:"Helvetica","sans-serif";
	color:#F0F0F0;}
p.warn1, li.warn1, div.warn1
	{mso-style-name:warn1;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.notice1, li.notice1, div.notice1
	{mso-style-name:notice1;
	margin-right:0in;
	margin-left:0in;
	font-size:16.5pt;
	font-family:"Times New Roman","serif";}
p.arrowtab1, li.arrowtab1, div.arrowtab1
	{mso-style-name:arrowtab1;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	background:#F8F8F8;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";}
p.thistab1, li.thistab1, div.thistab1
	{mso-style-name:thistab1;
	margin-right:0in;
	margin-left:0in;
	text-align:center;
	background:#F6F6F6;
	border:none;
	padding:0in;
	font-size:9.5pt;
	font-family:"Arial","sans-serif";
	font-weight:bold;}
p.onelinesource1, li.onelinesource1, div.onelinesource1
	{mso-style-name:one_line_source1;
	margin-right:0in;
	margin-left:0in;
	background:#E0E0E0;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
p.mathjaxhoverarrow1, li.mathjaxhoverarrow1, div.mathjaxhoverarrow1
	{mso-style-name:mathjax_hover_arrow1;
	margin-right:0in;
	margin-left:0in;
	border:none;
	padding:0in;
	font-size:7.0pt;
	font-family:"Courier New";
	color:#F0F0F0;}
p.mathjaxmenuarrow1, li.mathjaxmenuarrow1, div.mathjaxmenuarrow1
	{mso-style-name:mathjax_menuarrow1;
	margin-right:0in;
	margin-left:0in;
	font-size:9.0pt;
	font-family:"Arial Unicode MS","serif";
	color:white;}
span.fm-vol-iss-date
	{mso-style-name:fm-vol-iss-date;}
span.doi1
	{mso-style-name:doi1;}
span.fm-citation-ids-label
	{mso-style-name:fm-citation-ids-label;}
span.before-email-separator
	{mso-style-name:before-email-separator;}
span.email-label
	{mso-style-name:email-label;}
p.p, li.p, div.p
	{mso-style-name:p;
	margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";}
span.kwd-text
	{mso-style-name:kwd-text;}
span.figpopup-sensitive-area1
	{mso-style-name:figpopup-sensitive-area1;
	text-decoration:none none;}
span.citation
	{mso-style-name:citation;}
span.ref-journal
	{mso-style-name:ref-journal;}
span.ref-vol
	{mso-style-name:ref-vol;}
span.nowrap
	{mso-style-name:nowrap;}
span.ref-title
	{mso-style-name:ref-title;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Tahoma","sans-serif";}
.MsoChpDefault
	{font-family:"Calibri","sans-serif";}
.MsoPapDefault
	{margin-bottom:10.0pt;
	line-height:115%;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>

</head>

<body lang=EN-US link=blue vlink=purple>

<div class=WordSection1>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Published
online 2008 Jul 1. doi:&nbsp; </span><a
href="http://dx.doi.org/10.1038%2Fsj.bjc.6604469" target="pmc_ext"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>10.1038/sj.bjc.6604469</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PMCID:
PMC2480968</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:24.0pt;font-family:"Times New Roman","serif"'>Mutations in the
LKB1 tumour suppressor are frequently detected in tumours from Caucasian but
not Asian lung cancer patients</span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Koivunen%20JP%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>J P
Koivunen</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>1,2</sup>
</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kim%20J%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>J Kim</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>3,4</sup>
</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lee%20J%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>J Lee</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>3,4</sup>
</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Rogers%20AM%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>A M
Rogers</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>2</sup>
</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Park%20JO%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>J O Park</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>1,2</sup>
</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Zhao%20X%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>X Zhao</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>2</sup>
</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Naoki%20K%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>K Naoki</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>2</sup>
</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Okamoto%20I%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>I Okamoto</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>5</sup>
</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Nakagawa%20K%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>K
Nakagawa</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>5</sup>
</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Yeap%20BY%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>B Y Yeap</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>6</sup>
</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Meyerson%20M%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>M
Meyerson</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>1,2,7,8,9</sup>
</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Wong%20KK%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>K-K Wong</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>1,2,9</sup>
</span><a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Richards%20WG%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>W G
Richards</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>10</sup>
</span><a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Sugarbaker%20DJ%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>D J
Sugarbaker</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>10</sup>
</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Johnson%20BE%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>B E
Johnson</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>,<sup>1,2,9</sup>
and </span><a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J%26%23x000e4%3Bnne%20PA%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>P A
J�nne</span></a><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>1,2,9,*</span></sup></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none'>1</span></sup><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";display:none'>Lowe Center for Thoracic Oncology,
Dana-Farber Cancer Institute, Boston, MA, USA</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none'>2</span></sup><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";display:none'>Department of Medical Oncology,
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none'>3</span></sup><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";display:none'>Department of Thoracic Surgery, Samsung
Medical Center, Seoul, Korea</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none'>4</span></sup><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";display:none'>School of Medicine, Sungkyunkwan
University, Seoul, Korea</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none'>5</span></sup><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";display:none'>Department of Medical Oncology, School
of Medicine, Kinki University, Osaka, Japan</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none'>6</span></sup><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";display:none'>Department of Medicine, Massachusetts
General Hospital, Boston, MA, USA</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none'>7</span></sup><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";display:none'>Department of Pathology, Harvard
Medical School, Boston, MA, USA</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none'>8</span></sup><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";display:none'>The Broad Institute of MIT and Harvard
Universities, Cambridge, MA, USA</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none'>9</span></sup><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";display:none'>Department of Medicine, Brigham and
Women's Hospital and Harvard Medical School, Boston, MA, USA</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none'>10</span></sup><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";display:none'>Department of Surgery, Brigham and
Women's Hospital, Boston, MA, USA</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none'>*</span></sup><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";display:none'>Author for correspondence: Email: </span><a
href="mailto:dev@null"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none'>gro.srentrap@ennajp</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Author
information &#9658;</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'> </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Article notes
&#9658;</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>
</span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Copyright
and License information &#9658;</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none'>Revised 2008 May 9; Accepted 2008 May 28.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none'>Copyright</span></a><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";display:none'> 2008, Cancer Research UK</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>This
article has been </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/citedby/"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>cited by</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'> other
articles in PMC.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif"'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN style='font-size:18.0pt;font-family:"Times New Roman","serif";
text-transform:uppercase'>Abstract</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>Somatic mutations of <i>LKB1</i>
tumour suppressor gene have been detected in human cancers including non-small
cell lung cancer (NSCLC). The relationship between <i>LKB1</i> mutations and
clinicopathological characteristics and other common oncogene mutations in
NSCLC is inadequately described. In this study we evaluated tumour specimens
from 310 patients with NSCLC including those with adenocarcinoma, adenosquamous
carcinoma, and squamous cell carcinoma histologies. Tumours were obtained from
patients of US (<i>n</i>=143) and Korean (<i>n</i>=167) origin and screened for
<i>LKB1</i>, <i>KRAS</i>, <i>BRAF</i>, and <i>EGFR</i> mutations using
RT�PCR-based SURVEYOR-WAVE method followed by Sanger sequencing. We detected
mutations in the <i>LKB1</i> gene in 34 tumours (11%). <i>LKB1</i> mutation
frequency was higher in NSCLC tumours of US origin (17%) compared with 5% in
NSCLCs of Korean origin (<i>P</i>=0.001). They tended to occur more commonly in
adenocarcinomas (13%) than in squamous cell carcinomas (5%) (<i>P</i>=0.066). <i>LKB1</i>
mutations associated with smoking history (<i>P</i>=0.007) and <i>KRAS</i>
mutations (<i>P</i>=0.042) were almost mutually exclusive with <i>EGFR</i>
mutations (<i>P</i>=0.002). The outcome of stages I and II NSCLC patients
treated with surgery alone did not significantly differ based on <i>LKB1</i>
mutation status. Our study provides clinical and molecular characteristics of
NSCLC, which harbour <i>LKB1</i> mutations.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Keywords:
</span></b><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>carcinoma,
non-small cell lung, mutation, LKB1, EGFR, KRAS</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>Peutz�Jeghers syndrome (PJS) is
caused by mutations in the <i>LKB1</i> tumour suppressor gene (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib14">Hemminki <i>et
al</i>, 1998</a>). LKB1 is serine�threonine kinase, which has been shown to
regulate cell cycle progression, apoptosis, and cell polarity (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib29">Tiainen <i>et
al</i>, 1999</a>). The major target of LKB1 kinase activity is thought to be
AMP-activated protein kinase (AMPK). AMPK is activated under low cellular
energy conditions by raising AMP levels and it phosphorylates multiple
downstream targets including tuberosclerosis complex 2 gene, which represses
mTOR signalling. Phosphorylation of AMPK by LKB1 is needed for full activity of
AMPK and suppression of mTOR activity under low energy conditions (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib28"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Shaw <i>et
al</i>, 2004</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
The hallmarks of PJS include mucocutaneous pigmentation and hamartomatous
polyps of the gastrointestinal tract. Patients with PJS have an increased risk
of developing gastrointestinal, pancreatic, breast, gynecological, and
non-small cell lung cancers (NSCLC). The overall risk for cancers is increased
5- to 12-fold in different age groups compared with the general population (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib13">Hearle <i>et
al</i>, 2006</a>). Somatic mutations of the <i>LKB1</i> tumour suppressor have
rarely been found in cancers from patients who do not have PJS except for NSCLC
(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib3">Avizienyte
<i>et al</i>, 1999</a>). Previous reports have suggested the <i>LKB1</i>
mutation rate to be as high as 30% in NSCLC tumours and cell lines derived from
patients of Caucasian origin (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib9">Carretero <i>et
al</i>, 2004</a>; </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib22"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Matsumoto
<i>et al</i>, 2007</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>) and to be infrequent in NSCLC patients of Asian
origin (3%) (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib25">Onozato <i>et
al</i>, 2007</a>). Furthermore, <i>LKB1</i> mutations have been shown to be
associated with adenocarcinoma histology, male gender, and smoking history (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib22"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Matsumoto
<i>et al</i>, 2007</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>). A recent report of using a mouse model for <i>lkb1</i>
inactivation in NSCLC has provided insights into the role of the gene in this
cancer. This study showed that <i>lkb1</i> inactivation in combination with
activating mutations of <i>kras</i> using inducible promoters in the lung was
associated with decreased survival compared with <i>kras</i> mutation alone (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib17"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Ji <i>et
al</i>, 2007</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>Current screening techniques for <i>LKB1</i>
tumour suppressor mutations rely on conventional exonic sequencing of the DNA,
which can identify single base pair changes and small deletions/insertions (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib5">Ballhausen and
Gunther, 2003</a>). The addition of multiple ligation-dependent probe
amplification (MLPA), which enables detection of exonic and whole gene
deletions, with exonic sequencing has increased the mutation detection rates to
80% in patients with PJS phenotype (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib31">Volikos <i>et
al</i>, 2006</a>). Conventional sequencing has also been used to detect
mutations of <i>LKB1</i> at mRNA level and some mutations missed by sequencing
at the DNA level have been discovered by mRNA-based approaches (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib1"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Abed <i>et al</i>,
2001</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
However, mutant forms of <i>LKB1</i> mRNAs can have a shortened half-life
because of nonsense-mediated decay, which can potentially interfere with
mutation detection (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib1"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Abed <i>et al</i>,
2001</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>We have recently described a
rapid and sensitive enzymatic method to detect mutations in epidermal growth
factor (<i>EGFR</i>) of DNA from fresh tissue and paraffin-embedded tissues (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib15">Janne <i>et
al</i>, 2006</a>). This method includes amplification of region of interest
with PCR, SURVEYOR endonuclease digestion of the products, which cleaves
mismatched heteroduplex DNAs, and detection of DNA fragments by sensitive
high-performance liquid chromatography (HPLC) WAVE HS system. Subsequently,
SURVEYOR-positive specimens are fractionated in partially denaturing conditions
and are Sanger-sequenced. The major advantages of SURVEYOR-WAVE method are the
fast exclusion of wild-type specimens without laborious conventional sequencing
and high sensitivity. The SURVEYOR-WAVE method is more sensitive than
conventional sequencing as it can detect mutant DNA sequences when they are present
in 1% or more of total DNA (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib15">Janne <i>et
al</i>, 2006</a>).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>The current study was designed to
analyse the incidence of <i>LKB1</i> mutations in NSCLC. Furthermore, we wanted
to investigate the <i>LKB1</i> mutational frequency in different histologies
and ethnic backgrounds, and assess their correlation to smoking history,
gender, stage, survival, and other oncogenic mutations in NSCLC.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif"'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN style='font-size:18.0pt;font-family:"Times New Roman","serif";
text-transform:uppercase'>Materials and Methods</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif"'>Cell lines and
tumour specimens </span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>The NSCLC cell lines A549,
NCI-H1395, NCI-H1650, NCI-H1666, NCI-H1781, NCI-1975, NCI-H23, NCI-H2126,
NCI-H441, NCI-H820, HCC2935, HCC4006, and HCC827 were purchased from ATCC
(Manassas, VA, USA). H3255, H3255GR, HCC2279, and PC-9 have been previously
described (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib24"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Ono <i>et
al</i>, 2004</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>;
</span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib30"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Tracy <i>et
al</i>, 2004</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>;
</span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib10"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Engelman
<i>et al</i>, 2006</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>). Ma1, and Ma70 are NSCLC cell lines harbouring <i>EGFR</i>
mutations that were established at the Kinki University, Osaka, Japan. A549,
NCI-H1395, NCI-H1666, NCI-H23, NCI-H2122, NCI-H2126, and NCI-H460 have
previously been reported to contain <i>LKB1</i> mutations (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib27"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Sanchez-Cespedes
<i>et al</i>, 2002</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>; </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib6"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Bamford <i>et al</i>,
2004</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>;
</span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib9"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Carretero
<i>et al</i>, 2004</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>NSCLC tumours (<i>n</i>=310) were
collected from surgical resections from patients with stages I�IV NSCLC when
sufficient material for RNA extraction was available. The majority of the
specimens (<i>n</i>=167) was collected at the Samsung Medical Center, Seoul,
Korea. Frozen tumour tissues were collected from 809 out of 2442 patients who
underwent curative resection for NSCLC from November 1995 to February 2007 at
Samsung Medical Center. One or two pieces from the periphery of the tumour
masses � avoiding necrotic regions � were immediately frozen at �80�C until
retrieved. Medical records and haematoxylin and eosin-stained slides of the
specimen were reviewed by a single pathologist. Only frozen tumour tissues from
adenocarcinoma or squamous cell carcinoma (according to the 2004 World Health
Organization histopathological criteria) were included. Only frozen tumour
tissues with a tumour cell content of more than 70% were used for further
analysis. In addition, frozen tumour tissues of the following patients were
excluded from the study: patients who had received preoperative neoadjuvant
treatments, patients with double primary lung cancer, and patients who had
undergone incomplete resections or who had not been subjected to mediastinal
lymph node dissections. Selected frozen tumour tissues were used for the
microdissection. Briefly, frozen tissues were lightly stained with
haematoxylin�eosin to improve visualisation, and necrotic tumour tissues and
intervening normal tissues were removed. Each of the microdissected tumour tissues
with a tumour cell content of more than 90% was placed in 1&#8201;ml Easy Blue
reagent of a commercially available RNA isolation kit (easy-spin� Total RNA
Extraction Kit, iNtRON Biotechnology, Gyeonggi-do, Korea), immediately
homogenised by vortexing, and the total RNA was extracted. The quantity and
quality of RNA were analysed using a spectrometer (Nanodrop Technologies,
Rockland, DE, USA) and Agilent 2100 Bioanalyzer (Agilent RNA 6000 Nano Kit,
Agilent Technologies Inc., B�blingen, Germany), respectively. Finally, 167
frozen tissues with acceptable quality of RNA (RNA Integrity Number (RIN) value
over 7.0) were used for the current studies. All patients provided written
informed consent.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>The tumours from Caucasian
patients (<i>n</i>=143) were collected at the Brigham and Women's Hospital,
Boston, MA, USA between 1991 and 1997 and have been previously published for
patient characteristics and histology, and for expression profile-based
clustering of the tumours (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib7">Bhattacharjee <i>et
al</i>, 2001</a>; </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib12"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Hayes <i>et
al</i>, 2006</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
Frozen samples of resected lung tumours were obtained within 30&#8201;min of
resection and subdivided into 100&#8201;mg samples and snap frozen at
&#8722;80�C. Each specimen was associated with an immediately adjacent sample
embedded for histology in an optimal cutting temperature medium and stored at
&#8722;80�C. Six micrometres of frozen sections of embedded samples stained
with haematoxylin and eosin were used to confirm the postoperative pathological
diagnosis and to estimate the cellular composition of adjacent samples. All
specimens underwent pathological review by two pathologists. In all 109 tumours
obtained during the same time period were excluded because they did not meet
one or more of the eligibility criteria. Tissue samples were homogenised in
Trizol (Life Technologies, Gaithersburg, MD, USA) and RNA was extracted and
purified by using the RNeasy column purification kit (Qiagen, Chatsworth, CA,
USA). Denaturing formaldehyde gel electrophoresis followed by northern blotting
using a <i>&#946;</i>-actin probe assessed RNA integrity. Samples were excluded
if <i>&#946;</i>-actin was not full length. All patients provided written
informed consent. The US cohort included specimens that have previously
undergone analyses and the results have been published for <i>EGFR, KRAS</i>,
and <i>BRAF</i> mutations (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib7">Bhattacharjee <i>et
al</i>, 2001</a>; </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib23"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Naoki <i>et
al</i>, 2002</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>;
</span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib12"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Hayes <i>et
al</i>, 2006</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
We reconfirmed the mutations in 30 of these specimens using the SURVEYOR-based
analysis (see section SURVEYOR digestion and HPLC analysis) and found 100%
concordance between the two methods (data not shown).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>Cell line specimens were snap
frozen and stored at �80�C. RNA was extracted from tumours and cell lines using
Trizol (Invitrogen, Carlsbad, CA, USA), purified with Rneasy Mini Kit (Qiagen,
Valencia, CA, USA) and was used for cDNA synthesis using the QuantiTect reverse
transcription kit (Qiagen, Valencia, CA, USA).</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif"'>PCR primers and
cycling conditions </span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>For <i>LKB1</i> gene analysis,
PCR primers were designed to amplify the cDNA in two amplicons. PCR primers of
the first amplicon were designed to hybridise to the noncoding area of the mRNA
upstream of exon 1 (5&#8242;-agggaagtcggaacacaagg-3&#8242;) and to exon 5
(5&#8242;-ccagatgtccaccttgaagc-3&#8242;) generating a PCR product of
797&#8201;bp. The primers for the second amplicon located at exon 5 (5&#8242;-aacggcctggacaccttct-3&#8242;)
and to noncoding exon 10 (5&#8242;-gaaccggcaggaagactgag-3&#8242;) generating a
product of 702&#8201;bp, which has an overlapping part with first amplicon. For
SURVEYOR-WAVE analysis of <i>KRAS</i>, PCR primers
(5&#8242;-ggcctgctgaaaatgactga-3&#8242;,
5&#8242;-tcctgagcctgttttgtgtct-3&#8242;) were designed to generate an amplicon
of 407&#8201;bp covering codons 12, 13 and 61, which are the codons commonly
mutated in lung cancers. For SURVEYOR-WAVE mutation analysis of <i>BRAF</i>,
cDNA was amplified in two overlapping amplicons
(5&#8242;-aggatttcgtggtgatggag-3&#8242;, 5&#8242;-gatgacttctggtgccatcc-3&#8242;,
and 5&#8242;-gacgggactcgagtgatgat-3&#8242;,
5&#8242;-ggtatcctcgtcccaccata-3&#8242;) covering codons 387�673. For
SURVEYOR-WAVE analysis of <i>EGFR</i>, PCR amplification was done in a single
amplicon (5&#8242;-ggagcctcttacacccagtg-3&#8242;,
5&#8242;-aggtcatcaactcccaaacg-3&#8242;), which covered exons 18�21 of the gene.
PCR amplification was done using JumpStart Taq (Sigma, St Louis, MO, USA) under
the manufacturer's guidelines. A part of the specimens (<i>n</i>=103) was
previously characterised for <i>KRAS, BRAF, EGFR</i> mutations using reverse
transcritase (RT)�PCR and direct sequencing of the PCR products (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib23"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Naoki <i>et
al</i>, 2002</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>;
</span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib12"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Hayes <i>et
al</i>, 2006</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif"'>SURVEYOR
digestion and HPLC analysis </span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>SURVEYOR digestion and HPLC
analysis were carried out as described previously (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib15">Janne <i>et
al</i>, 2006</a>). In brief, PCR products were digested in reaction mixture
containing equal volumes of SURVEYOR enzyme (Transgenomics, Omaha, NE, USA) and
Enhancer (Transgenomics, Omaha, NE, USA) at 42�C for 20&#8201;min followed by
termination of the reaction by Stop Solution (Transgenomics, Omaha, NE, USA). Specimens
were then loaded to the WAVE HS HPLC (Transgenomics, Omaha, NE, USA) at 50�C,
eluted with an increasing acetonitrile gradient, and detected by UV detector
using DNA intercalating fluorescence dye (Transgenomics, Omaha, NE, USA). When
cell lines known to be homozygous for specific mutation were analysed, PCR
products were mixed 1&#8201;:&#8201;1 with PCR products of a wild-type cell
line, denatured by heating, and slowly renatured to generate heteroduplexes.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif"'>Sequencing and
fractionation </span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>Specimens that showed an altered
pattern on the SURVEYOR tracings were purified using QIAquick kit (Qiagen,
Valencia, CA, USA) and sequenced bi-directionally by molecular biology core
facility of Dana�Farber Cancer Institute. If a specimen showed an altered
pattern on the SURVEYOR tracing but had a wild-type sequence by direct DNA
sequencing, it underwent fractionation by WAVE HS HPLC in partially denaturing
conditions. Running temperatures for specific amplicons were calculated by the
Navigator Software (Transgenomics, Omaha, NE, USA). Collected fragments were
amplified with PCR using the same primers as in the original amplification,
purified and sequenced as previously described above.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif"'>Statistical
analysis </span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>Fisher's exact test was used to
assess the association of <i>LKB1</i> mutation status with other clinical,
pathological, and genetic characteristics. To adjust for any difference between
ethnic groups, the association between <i>LKB1</i> mutation rate and each
characteristic was also evaluated as stratified contingency tables. If we did
not reject that the odds ratios were the same across ethnic groups, we then
tested whether the common odds ratios were unity based on the stratified Mantel�Haenszel
estimate (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib8"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Breslow and Day,
1980</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
Overall survival was estimated using the Kaplan�Meier method, with differences
between the groups compared using the log-rank test. All <i>P</i>-values were
based on a two-sided hypothesis, with <i>P</i>&lt;0.05 considered to be
statistically significant and 0.05&lt;<i>P</i>&lt;0.10 considered to be
borderline significant.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif"'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN style='font-size:18.0pt;font-family:"Times New Roman","serif";
text-transform:uppercase'>Results</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif"'>SURVEYOR-WAVE
mutation detection of <i>LKB1</i> tumour suppressor in NSCLC cell lines </span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>The impact of the stability of <i>LKB1</i>
mRNA on detecting <i>LKB1</i> mutations was tested using RT�PCR with mRNA
extracted from NSCLC cell lines that had previously been characterised for <i>LKB1</i>
mutations. These included NCI-H441 (wild type) and A549, NCI-H1395, NCI-H23,
and NCI-H2126 (all containing <i>LKB1</i> mutations). Reverse transcriptase�PCR
amplification of the whole coding region of the <i>LKB1</i> mRNA showed that
cell lines with nonsense (A549, NCI-H23) mutations or 1&#8201;bp deletion
(H1395) expressed mRNA with comparable size to the wild-type H441 cell line
(1460&#8201;bp). H2126 cell line, which is known to have homozygous deletion of
exons 4�6, expressed mRNA with substantially smaller size (</span><span
lang=EN style='font-size:12.0pt;font-family:"Cambria Math","serif"'>&#8764;</span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>1000&#8201;bp)
corresponding to deletion of 398&#8201;bp. RT�PCR revealed no major difference
in <i>LKB1</i> mRNA expression levels between <i>LKB1</i> mutant or wild-type
cell lines (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/figure/fig1/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Figure
1A</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/figure/fig1/"
target=figure><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
text-decoration:none'><img border=0 width=96 height=115 id="Picture 6"
src="PMC%202480968%20table%202_files/image001.gif" alt="Figure 1"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/figure/fig1/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Figure
1</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Mutation
analysis of <i>LKB1</i> gene in NSCLC cell lines and tumours. RT�PCR
amplification of cDNA from <i>LKB1</i> wt (H441) and <i>LKB1</i> mutant (A549,
H1395, and H23) cell lines display the full length LKB1 mRNA (1.4&#8201;kbp)
while the <i>LKB1</i> mutant cell line, <b>...</b></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>As <i>LKB1</i> mutant and
wild-type cell lines expressed comparable amounts of <i>LKB1</i> mRNA with
RT�PCR, we studied the cDNA for mutations using the SURVEYOR-WAVE method. The
WAVE HPLC provides a system to analyse DNA fragments smaller than 900&#8201;bp
and therefore we designed two overlapping amplicons covering exons 1�5
(797&#8201;bp) and 5�9 (702&#8201;bp) to amplify the whole coding region of <i>LKB1</i>
mRNA. PCR products of <i>LKB1</i> mutant cell lines were mixed
1&#8201;:&#8201;1 with the products from wild-type cell lines (H441) to
generate heteroduplexes as <i>LKB1</i> mutant cell lines were previously
reported to be homozygous for the inactivation of the gene. SURVEYOR-WAVE
analysis of the amplicon covering exons 1�5 revealed novel peaks with the cDNA
for A549, and NCI-H1395 cell lines compared with the wild type from NCI-H441 (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/figure/fig1/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Figure
1B</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
SURVEYOR-WAVE analysis of exons 5�9 showed novel peaks for the NCI-H23 cell
line as well. The mutations detected with SURVEOR-WAVE were confirmed by
conventional DNA sequencing and they corresponded to previous reports (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib27"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Sanchez-Cespedes
<i>et al</i>, 2002</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>; </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib9"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Carretero <i>et
al</i>, 2004</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
We could not detect the <i>LKB1</i> mutation of H2126 cell line with
SURVEYOR-WAVE method using a two-amplicon approach because this cell line has a
homozygous deletion of exons 4�6 and the reverse primer of the first amplicon
and the forward primer of the second amplicon, which lie on the deleted part of
the gene (data not shown).</span></p>

<p class=MsoNormal style='line-height:normal'><b><i><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif"'>LKB1</span></i></b><b><span
lang=EN style='font-size:13.5pt;font-family:"Times New Roman","serif"'> tumour
suppressor gene mutations in NSCLC tumours </span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>We next used the SURVEYOR-WAVE
method to screen NSCLC tumour specimens (<i>n</i>=310) for <i>LKB1</i>
mutations. We detected 34 <i>LKB1</i> mutations (11%) in the NSCLC tumour
specimens (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl1/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
1</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
<span style='background:yellow'>The majority of the <i>LKB1</i> mutations
detected was deletions or insertions (<i>n</i>=25, 74%).</span> <span
style='background:yellow'>The remainder was missense (<i>n</i>=7, 21%) and
nonsense (<i>n</i>=2, 6%) mutations (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl2/"
target=true>Table 2</a>, <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/figure/fig1/"
target=figure>Figure 1C</a>).</span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'> <span
style='background:yellow'>About one-half of the deletions and insertions were
small, covering &lt;15&#8201;bp (<i>n</i>=14, 56%), whereas larger deletions (<i>n</i>=11,
44%) covering hundreds of base pairs were detected in the remaining specimens.</span>
<span style='background:yellow'>Some mutational hotspots were discovered.</span>
<span style='background:yellow'>The areas that had the same mutation in more
than one tumour specimen included deletion of exon 4 (<i>n</i>=4), deletion of
exons 2 and 3 (<i>n</i>=3), D194Y (<i>n</i>=2), and P281L (<i>n</i>=2).</span> <span
style='background:yellow'>Interestingly, a significant portion of the mutations
was located in exon 1 (<i>n</i>=11, 32%) but there was no area of recurrent
mutations in this exon (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl2/"
target=true>Table 2</a>).</span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'> <span
style='background:yellow'>Of the missense mutations detected in the current
study, all except R426W are in the kinase domain of the protein.</span>
Missense mutations in codons 176 and 194 have been previously characterised in
PJS (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib19">Launonen,
2005</a>). We also found four F354L alterations (data not shown) but we did not
consider these as missense mutations as this alteration has previously been
reported to be a rare polymorphism of the gene (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib20">Launonen <i>et
al</i>, 2000</a>). We did not have access to the corresponding normal tissues
and therefore, we could not verify if some of the missense mutations were
somatic or germline.</span></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl1/"
target=table><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
text-decoration:none'><img border=0 width=202 height=163 id="Picture 5"
src="PMC%202480968%20table%202_files/image002.png" alt="Table 1"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl1/"
target=table><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
1</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Frequency
of <i>LKB1</i> mutations in NSCLC tumours and their association with
clinicopathological characteristics</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl2/"
target=table><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
text-decoration:none'><img border=0 width=202 height=144 id="Picture 4"
src="PMC%202480968%20table%202_files/image003.png" alt="Table 2"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl2/"
target=table><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
2</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
background:yellow'>The specific <i>LKB1</i> mutations in NSCLC tumours</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif"'>Association of <i>LKB1</i>
tumour suppressor mutations in NSCLC with clinicopathological characteristics </span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>The mutation frequency of <i>LKB1</i>
gene was significantly higher in NSCLCs in the Caucasian cohort (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl1/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
1</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
Twenty-five (17% of specimens) of the <i>LKB1</i> mutations were detected in
NSCLCs collected from patients in the United States, whereas only nine
mutations (5% of specimens) were detected in the Korean cohort (<i>P</i>=0.001)
(</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl1/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
1</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
The <i>LKB1</i> mutation rate tended to be higher in adenocarcinomas (13%)
compared with squamous cell carcinomas (5%) (<i>P</i>=0.067). Differences in
histological subgroups were relatively modest in the US cohort with mutations
in 18 out of 94 (19%) adenocarcinomas <i>vs</i> 5 out of 38 (13%) in squamous
cell cancers (<i>P</i>=0.461). This is in contrast to the findings in the Asian
patients where all of the <i>LKB1</i> mutations were detected in
adenocarcinomas (9 out of 113 (8%)) and none were detected in squamous cell
cancers (0 out of 54 (0%); <i>P</i>=0.032). Nevertheless, the higher rate of <i>LKB1</i>
mutation in adenocarcinomas compared with squamous cell carcinomas retains the
same level of statistical significance (stratified <i>P</i>=0.064) after
adjusting for fluctuation between ethnic groups. The US cohort also included
nine specimens from adenosquamous carcinomas and two out of nine (22%) had <i>LKB1</i>
mutations, which is similar to the frequency in adenocarcinomas in this
population (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl1/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
1</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
There was no association between <i>LKB1</i> mutations and the clinical stage
of the NSCLC patients. Kaplan�Meier survival curves of stages I and II NSCLC
patients showed a tendency for shorter survival in patients with <i>LKB1</i>
mutant tumours but this, however, did not reach statistical significance (<i>P</i>=0.17)
(</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/figure/fig2/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Figure
2</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
No differences in survival were observed in patients who harboured both <i>LKB1</i>
and <i>KRAS</i> mutations compared with those with <i>KRAS</i> or <i>LKB1</i>
alone but the total number of patients with both mutations who had stages I or
II NSCLC was small (<i>n</i>=9; data not shown). We detected an association of <i>LKB1</i>
mutations with a smoking history (<i>P</i>=0.007) and only two mutations were
detected in tumours from 72 NSCLC patients who were either never or light (</span><span
lang=EN style='font-size:12.0pt;font-family:"Cambria Math","serif"'>&#10877;</span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>10 pack
years) former smokers (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl1/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
1</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
After adjusting for ethnic group, the higher rate of <i>LKB1</i> mutation among
patients with a smoking history is borderline significant (stratified <i>P</i>=0.067).
The reduction in statistical significance is likely owing to the loss of power
associated with the overall rarity of <i>LKB1</i> mutations among never or
light former smokers. For these analyses we combined both never smokers and
light (</span><span lang=EN style='font-size:12.0pt;font-family:"Cambria Math","serif"'>&#10877;</span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>10 pack
years) smokers as the frequency of mutations in other oncogenes such as <i>EGFR</i>
is similar in these two patient groups (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib26"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Pham <i>et
al</i>, 2006</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
There were no correlations between <i>LKB1</i> mutations and gender or age of a
patient.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/figure/fig2/"
target=figure><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
text-decoration:none'><img border=0 width=96 height=67 id="Picture 3"
src="PMC%202480968%20table%202_files/image004.jpg" alt="Figure 2"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/figure/fig2/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Figure
2</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Kaplan�Meyer
survival curves of stage I and II NSCLC patients with LKB1 wildtype (red line, <i>n</i>=198)
<i>vs</i> LKB1 mutant (blue line, <i>n</i>=23) tumours.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif"'>Association of <i>LKB1</i>
mutations with <i>K-Ras</i>, <i>B-Raf</i>, and <i>EGFR</i> mutations in NSCLC </span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>Previous reports have suggested
that in NSCLC cell lines, <i>LKB1</i> mutations often occur concurrently with <i>KRAS</i>
or <i>BRAF</i> mutations (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib27"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Sanchez-Cespedes
<i>et al</i>, 2002</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>; </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib9"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Carretero <i>et
al</i>, 2004</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
Furthermore, <i>EGFR</i> mutations are often mutually exclusive with <i>KRAS</i>
mutations in NSCLC (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib18">Kosaka <i>et
al</i>, 2004</a>; </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib21"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Marchetti
<i>et al</i>, 2005</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>). We used combined data from previous papers (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib27"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Sanchez-Cespedes
<i>et al</i>, 2002</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>; </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib9"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Carretero <i>et
al</i>, 2004</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>)
and from Sanger institute's databases (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib6"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Bamford <i>et al</i>,
2004</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>)
to analyse association of <i>LKB1</i> mutations with mutations of <i>KRAS</i>, <i>BRAF</i>,
and <i>EGFR</i>. Analysis of <i>LKB1</i> mutation harbouring NSCLC cell lines
(A-427, A549, NCI-H1395, NCI-H1666, NCI-H2122, NCI-H2126, NCI-H23, and
NCI-H460) showed that five of the cell lines (63%) had concurrent <i>LKB1</i>
and <i>KRAS</i> mutations, two (25%) had concurrent <i>LKB1</i> and <i>BRAF</i>
mutations, and only one (13%) had neither <i>KRAS</i> nor <i>BRAF</i>
mutations. None of these cell lines had EGFR mutations.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>As our findings in NSCLC cell
lines suggested concurrency of <i>KRAS</i> or <i>BRAF</i> and mutual
exclusiveness of <i>EGFR</i> mutations with LKB1 mutations, we analysed the
mutational status of these genes in our primary NSCLC tumour specimens. <i>KRAS</i>
mutations were detected in 49 (16% in the whole tumour set, 25% in Caucasian
and 8% in Asian specimens) tumour specimens with 10 (20% of <i>KRAS</i>
mutants) of these occurring concurrently with an <i>LKB1</i> mutation (<i>P</i>=0.042)
(</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl3/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
3</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
Four <i>BRAF</i> mutations (1%) were found in the tumour set (G465V, N581S,
L596R, and T599I) and one of these (N581S) occurred concurrently with <i>LKB1</i>
mutation (<i>P</i>=0.373). Seventy tumours (23% in the whole tumour set, 9% in
Caucasian, 34% in Asian specimens) had <i>EGFR</i> kinase domain mutations with
only one of them occurring concurrently with an <i>LKB1</i> mutation (<i>P</i>=0.002).
The tumour with a concurrent <i>EGFR</i> and <i>LKB1</i> mutation had a
missense mutation of <i>LKB1</i> outside the kinase domain (R426W). No germ
line DNA was available from this patient. However, a recent report has
suggested that R426W is in fact a rare polymorphism of the gene (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib25">Onozato <i>et
al</i>, 2007</a>). Taken together our findings suggest that unlike <i>KRAS</i>,
mutations in <i>EGFR</i> and <i>LKB1</i> are mutually exclusive in NSCLC.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl3/"
target=table><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
text-decoration:none'><img border=0 width=202 height=134 id="Picture 2"
src="PMC%202480968%20table%202_files/image005.png" alt="Table 3"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl3/"
target=table><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
3</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Association
of <i>LKB1</i> mutations with <i>KRAS</i>, <i>BRAF,</i> and <i>EGFR</i>
mutations in NSCLC tumours</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>Previous reports (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib27"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Sanchez-Cespedes
<i>et al</i>, 2002</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>; </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib9"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Carretero <i>et
al</i>, 2004</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>)
and Cancer Genome Project by Sanger Institute (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib6"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Bamford <i>et al</i>,
2004</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>)
have extensively characterised <i>LKB1</i> mutations in NSCLC cell lines with <i>KRAS</i>
and <i>BRAF</i> mutations, but <i>LKB1</i> status of <i>EGFR</i> mutant NSCLC
cell lines has not been extensively analysed. Therefore, we analysed the <i>LKB1</i>
genotype of NSCLC cell lines with known <i>EGFR</i> or <i>ERBB2</i> mutations.
Twelve <i>EGFR</i> mutant and one <i>ERBB2</i> mutant cell lines were analysed
for <i>LKB1</i> genotype. No <i>LKB1</i> mutations were detected in these cell
lines (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl4/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
4</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl4/"
target=table><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
text-decoration:none'><img border=0 width=202 height=163 id="Picture 1"
src="PMC%202480968%20table%202_files/image006.png" alt="Table 4"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl4/"
target=table><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
4</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>LKB1
genotypes of NSCLC cell lines with EGFR or ERBB2 mutations</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif"'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN style='font-size:18.0pt;font-family:"Times New Roman","serif";
text-transform:uppercase'>Discussion</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>The present study characterised <i>LKB1</i>
mutation frequency in NSCLC using one of the largest tumour sets to date (<i>n</i>=310).
Our study analysed tumours from different histologies and of both a US and
Korean origin to determine potential histological and ethnic variation in <i>LKB1</i>
mutational frequency. The large size of our study enabled us to study
associations of <i>LKB1</i> mutations with clinocopathological factors, which
have been incompletely characterised in previous studies (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib27"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Sanchez-Cespedes
<i>et al</i>, 2002</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>; </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib9"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Carretero <i>et
al</i>, 2004</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>;
</span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib11"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Fernandez
<i>et al</i>, 2004</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>; </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib22"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Matsumoto
<i>et al</i>, 2007</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>; </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib25"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Onozato <i>et
al</i>, 2007</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
In addition, we used a modification of a sensitive mutation screening technique
that we have previously developed to facilitate the rapid detection of <i>LKB1</i>
mutations (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib15">Janne
<i>et al</i>, 2006</a>).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>Findings from our study confirm
the high frequency of <i>LKB1</i> mutations in NSCLC (11%), which in contrast,
are rare (0�4%) in other common solid malignancies (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib4">Avizienyte <i>et
al</i>, 1998</a>, </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib3"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>1999</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>). The
reason behind these observations is presently unknown but might reflect the
differences in carcinogen exposure in the lungs compared with other tissues. In
support of this hypothesis, we find that <i>LKB1</i> mutations are significantly
(<i>P</i>=0.007) more common in smokers than in never or light (</span><span
lang=EN style='font-size:12.0pt;font-family:"Cambria Math","serif"'>&#10877;</span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>10 pack
years) cigarette smokers (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl1/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
1</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
Male PJS patients (age </span><span lang=EN style='font-size:12.0pt;font-family:
"Cambria Math","serif"'>&#10878;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif"'>50 years) have an increased risk of
developing lung cancer compared with the general population but the
relationship of smoking and the increased risk of lung cancer in PJS is unknown
(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib13">Hearle <i>et
al</i>, 2006</a>). Interestingly, the <i>LKB1</i> mutation spectrum found in
the current study is very similar to those previously published for PJS
(deletions 34%, insertions 15%, splice site mutations 14%, missense mutations
21%, and nonsense mutations 12%) (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib19">Launonen,
2005</a>) and, as in PJS, no clear mutational hotspots were detected.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>Our study also demonstrated that
the <i>LKB1</i> mutation frequency was significantly higher in cancers derived
from a US population compared with those found in Korean patients (17 <i>vs</i>
5%; <i>P</i>=0.001). These differences also track with cigarette smoking, as
the number of never/light former smokers was much higher in the Korean cohort
compared with the US cohort of patients (38 <i>vs</i> 13%). Similarly, a recent
study of 100 Japanese NSCLCs found that only 3% contained an <i>LKB1</i>
mutation (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib25">Onozato
<i>et al</i>, 2007</a>). These findings are in contrast to <i>EGFR</i>
mutations, which are more frequently detected in tumours from never/light
cigarette smokers and from Asian patients (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib16">Janne and
Johnson, 2006</a>). Our studies further highlight ethnic and environmental
differences in the origins of NSCLC.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>Given the differences in <i>LKB1</i>
mutation frequencies in smokers <i>vs</i> never/light smokers and in the US
compared with Korean patients, we further determined whether these were also
associated with other oncogene mutations known to vary in these subgroups of
patients. Consistent with prior studies we found a significant association with
concurrent <i>KRAS</i> mutations, which are common in smokers (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib2">Ahrendt <i>et
al</i>, 2001</a>), in one out of three of NSCLC with <i>LKB1</i> mutations (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl3/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
3</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
In contrast, there was a significant inverse relationship of <i>LKB1</i>
mutations with <i>EGFR</i> mutations in both NSCLC tumours and cell lines,
which has not previously been described (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl3/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Tables
3</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>
and </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl4/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>&#8203;</span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
text-decoration:none'>and4).</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif"'>4</span></a><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>). These
differences may relate to the biological role of LKB1 in lung cancer. It is
possible that in <i>EGFR</i> mutant lung cancers there is already maximal
activation of the PI3K/Akt/mTOR signalling pathway and thus an <i>LKB1</i>
mutation may not be required to further potentiate this signalling pathway. In
contrast in <i>KRAS</i> mutant cancers, a concurrent <i>LKB1</i> mutation may
be required to enhance mTOR activation. Mice with concurrent <i>KRAS</i>
mutations and <i>LKB1</i> inactivation have more aggressive tumours and a
shorter survival than those with only <i>KRAS</i> mutant cancers (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib17"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Ji <i>et
al</i>, 2007</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
In our study, we were not able to detect a significant survival difference for
patients whose tumours contained <i>LKB1</i> mutations alone or concurrently
with <i>KRAS</i> mutations (data not shown) likely because of the limited
number of tumour specimens. Additional studies are needed to clarify the
prognostic impact of <i>LKB1</i> mutations in humans with NSCLC. In the present
study </span><span lang=EN style='font-size:12.0pt;font-family:"Cambria Math","serif"'>&#8764;</span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>2 out of
3 of <i>LKB1</i> mutant tumours were <i>KRAS</i> wild type (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl3/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
3</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
One possibility is that such tumours contain a concurrent mutation in another
oncogene that activates the same signalling pathway as <i>KRAS.</i> For this
reason, we examined our tumours for <i>BRAF</i> mutations, which are found in
1�2% of NSCLC (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib23"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Naoki <i>et
al</i>, 2002</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
We detected a concurrent <i>LKB1</i> mutation in one of the four <i>BRAF</i>
mutant tumours (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl3/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
3</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>).
This tumour was wild type for <i>KRAS</i> (data not shown). In addition, some
of the <i>BRAF</i> mutant NSCLC cell lines (NCI-H1395, G469A; NCI-H1666, G466V)
also contain a concurrent <i>LKB1</i> mutation (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib27"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Sanchez-Cespedes
<i>et al</i>, 2002</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>; </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib6"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Bamford <i>et al</i>,
2004</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>;
</span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib9"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Carretero
<i>et al</i>, 2004</span></a><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif"'>). Future studies will help further clarify whether <i>LKB1</i>
mutations occur concurrently with other genomic alterations in NSCLC and the
impact of this on patient outcome.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>Our study employed a mutation
scanning technology to screen for <i>LKB1</i> mutations at the cDNA level (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib15">Janne <i>et
al</i>, 2006</a>). This was advantageous as the entire coding region of <i>LKB1</i>
could be rapidly screened for a mutation using just two overlapping cDNA
fragments. <i>LKB1</i> is a challenging gene to analyse at the genomic DNA
level because of its high guanine�cytosine content. In addition, as many of the
<i>LKB1</i> mutations are small deletions (</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/table/tbl2/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>Table
2</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>)
or involve deletions of entire exons, these would be missed using exon-specific
genome sequencing methods. Our method, however, does have limitations as it
would miss deletions at the site of PCR primers, whole gene deletions, or
deletions within the promoter region all of which have been infrequently
detected in PJS (<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/#bib31">Volikos <i>et
al</i>, 2006</a>). Thus our studies may underestimate the true <i>LKB1</i>
mutation frequency in NSCLC. In addition, our method is limited to the analysis
of fresh tumour specimens, which are available only from the minority of NSCLC
patients. Furthermore, as techniques isolating mRNA from formalin-fixed
paraffin-embedded tumour specimens continue to improve, this rapid mutation
scanning technique can be used to analyse broader populations of tumours from
NSCLC patients. Future studies may need to employ a combination of <i>LKB1</i>
mutation detection methodologies including the current method, MLPA and direct
sequencing.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif"'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN style='font-size:18.0pt;font-family:"Times New Roman","serif";
text-transform:uppercase'>Acknowledgments</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif"'>This study is supported by grants
from the National Institutes of Health 1RO1CA114465-01 (BYY, BEJ, and PAJ), the
National Cancer Institute Lung SPORE P20CA90578-02 (BYY and BEJ), American
Cancer Society RSG-06-102-01-CCE (BYY and PAJ), Finnish Medical Foundation
(JPK), Finnish Cultural Foundation (JPK), and Academy of Finland (JPK). PAJ, MM,
and BEJ are part of a pending patent application on <i>EGFR</i> mutations.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480968/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif"'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal;border:none;padding:0in'><b><span
lang=EN style='font-size:18.0pt;font-family:"Times New Roman","serif";
text-transform:uppercase'>References</span></b></p>

</div>

<ul type=disc>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Abed AA, Gunther K, Kraus C,
     Hohenberger W, Ballhausen WG. Mutation screening at the RNA level of the
     STK11/LKB1 gene in Peutz-Jeghers syndrome reveals complex splicing
     abnormalities and a novel mRNA isoform (STK11 c.597(insertion
     mark)598insIVS4) Hum Mutat. 2001;18:397�410. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11668633" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Ahrendt SA, Decker PA, Alawi
     EA, Zhu Yr YR, Sanchez-Cespedes M, Yang SC, Haasler GB, Kajdacsy-Balla A,
     Demeure MJ, Sidransky D. Cigarette smoking is strongly associated with
     mutation of the K-ras gene in patients with primary adenocarcinoma of the
     lung. Cancer. 2001;92:1525�1530. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11745231" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Avizienyte E, Loukola A,
     Roth S, Hemminki A, Tarkkanen M, Salovaara R, Arola J, Butzow R,
     Husgafvel-Pursiainen K, Kokkola A, Jarvinen H, Aaltonen LA. LKB1 somatic
     mutations in sporadic tumors. Am J Pathol. 1999;154:677�681. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868601/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PMC free
     article</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]
     [</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/10079245"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Avizienyte E, Roth S,
     Loukola A, Hemminki A, Lothe RA, Stenwig AE, Fossa SD, Salovaara R,
     Aaltonen LA. Somatic mutations in LKB1 are rare in sporadic colorectal and
     testicular tumors. Cancer Res. 1998;58:2087�2090. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/9605748" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Ballhausen WG, Gunther K.
     Genetic screening for Peutz-Jeghers syndrome. Expert Rev Mol Diagn.
     2003;3:471�479. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/12877386" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Bamford S, Dawson E, Forbes
     S, Clements J, Pettett R, Dogan A, Flanagan A, Teague J, Futreal PA,
     Stratton MR, Wooster R. The COSMIC (Catalogue of Somatic Mutations in
     Cancer) database and website. Br J Cancer. 2004;91:355�358. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409828/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PMC free
     article</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]
     [</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/15188009"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Bhattacharjee A, Richards
     WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R,
     Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub
     TR, Sugarbaker DJ, Meyerson M. Classification of human lung carcinomas by
     mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc
     Natl Acad Sci USA. 2001;98:13790�13795. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC61120/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PMC free
     article</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]
     [</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/11707567"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Breslow NE, Day NE, International
     Agency for Research on Cancer Statistical methods in cancer research
     1980International Agency for Research on Cancer: Lyon; Vol. 1. Analysis of
     case�control studies. IARC scientific publications; no. 32. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/7216345" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Carretero J, Medina PP, Pio
     R, Montuenga LM, Sanchez-Cespedes M. Novel and natural knockout lung
     cancer cell lines for the LKB1/STK11 tumor suppressor gene. Oncogene.
     2004;23:4037�4040. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/15021901" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Engelman JA, Mukohara T,
     Zejnullahu K, Lifshits E, Borras AM, Gale CM, Naumov GN, Yeap BY, Jarrell
     E, Sun J, Tracy S, Zhao X, Heymach JV, Johnson BE, Cantley LC, Janne PA.
     Allelic dilution obscures detection of a biologically significant
     resistance mutation in EGFR-amplified lung cancer. J Clin Invest.
     2006;116:2695�2706. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1570180/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PMC free
     article</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]
     [</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/16906227"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Fernandez P, Carretero J,
     Medina PP, Jimenez AI, Rodriguez-Perales S, Paz MF, Cigudosa JC, Esteller
     M, Lombardia L, Morente M, Sanchez-Verde L, Sotelo T, Sanchez-Cespedes M.
     Distinctive gene expression of human lung adenocarcinomas carrying LKB1
     mutations. Oncogene. 2004;23:5084�5091. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/15077168" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Hayes DN, Monti S,
     Parmigiani G, Gilks CB, Naoki K, Bhattacharjee A, Socinski MA, Perou C,
     Meyerson M. Gene expression profiling reveals reproducible human lung
     adenocarcinoma subtypes in multiple independent patient cohorts. J Clin
     Oncol. 2006;24:5079�5090. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/17075127" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Hearle N, Schumacher V, Menko
     FH, Olschwang S, Boardman LA, Gille JJ, Keller JJ, Westerman AM, Scott RJ,
     Lim W, Trimbath JD, Giardiello FM, Gruber SB, Offerhaus GJ, de Rooij FW,
     Wilson JH, Hansmann A, Moslein G, Royer-Pokora B, Vogel T, Phillips RK,
     Spigelman AD, Houlston RS. Frequency and spectrum of cancers in the
     Peutz-Jeghers syndrome. Clin Cancer Res. 2006;12:3209�3215. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/16707622" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Hemminki A, Markie D,
     Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff
     M, Hoglund P, Jarvinen H, Kristo P, Pelin K, Ridanpaa M, Salovaara R, Toro
     T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A,
     Aaltonen LA. A serine/threonine kinase gene defective in Peutz-Jeghers
     syndrome. Nature. 1998;391:184�187. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/9428765" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Janne PA, Borras AM, Kuang
     Y, Rogers AM, Joshi VA, Liyanage H, Lindeman N, Lee JC, Halmos B, Maher
     EA, Distel RJ, Meyerson M, Johnson BE. A rapid and sensitive enzymatic
     method for epidermal growth factor receptor mutation screening. Clin
     Cancer Res. 2006;12:751�758. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/16467085" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Janne PA, Johnson BE. Effect
     of epidermal growth factor receptor tyrosine kinase domain mutations on
     the outcome of patients with non-small cell lung cancer treated with
     epidermal growth factor receptor tyrosine kinase inhibitors. Clin Cancer
     Res. 2006;12:4416s�4420s. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/16857820" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Ji H, Ramsey MR, Hayes DN,
     Fan C, McNamara K, Kozlowski P, Torrice C, Wu MC, Shimamura T, Perera SA,
     Liang MC, Cai D, Naumov GN, Bao L, Contreras CM, Li D, Chen L,
     Krishnamurthy J, Koivunen J, Chirieac LR, Padera RF, Bronson RT, Lindeman
     NI, Christiani DC, Lin X, Shapiro GI, Janne PA, Johnson BE, Meyerson M,
     Kwiatkowski DJ, Castrillon DH, Bardeesy N, Sharpless NE, Wong KK. LKB1
     modulates lung cancer differentiation and metastasis. Nature.
     2007;448:807�810. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/17676035" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Kosaka T, Yatabe Y, Endoh H,
     Kuwano H, Takahashi T, Mitsudomi T. Mutations of the epidermal growth
     factor receptor gene in lung cancer: biological and clinical implications.
     Cancer Res. 2004;64:8919�8923. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/15604253" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Launonen V. Mutations in the
     human LKB1/STK11 gene. Hum Mutat. 2005;26:291�297. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/16110486" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Launonen V, Avizienyte E,
     Loukola A, Laiho P, Salovaara R, Jarvinen H, Mecklin JP, Oku A, Shimane M,
     Kim HC, Kim JC, Nezu J, Aaltonen LA. No evidence of Peutz-Jeghers syndrome
     gene LKB1 involvement in left-sided colorectal carcinomas. Cancer Res.
     2000;60:546�548. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/10676634" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Marchetti A, Martella C,
     Felicioni L, Barassi F, Salvatore S, Chella A, Camplese PP, Iarussi T,
     Mucilli F, Mezzetti A, Cuccurullo F, Sacco R, Buttitta F. EGFR mutations in
     non-small-cell lung cancer: analysis of a large series of cases and
     development of a rapid and sensitive method for diagnostic screening with
     potential implications on pharmacologic treatment. J Clin Oncol.
     2005;23:857�865. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/15681531" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Matsumoto S, Iwakawa R,
     Takahashi K, Kohno T, Nakanishi Y, Matsuno Y, Suzuki K, Nakamoto M,
     Shimizu E, Minna JD, Yokota J. Prevalence and specificity of LKB1 genetic
     alterations in lung cancers. Oncogene. 2007;26:5911�5918. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457639/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PMC free
     article</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]
     [</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/17384680"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Naoki K, Chen TH, Richards
     WG, Sugarbaker DJ, Meyerson M. Missense mutations of the BRAF gene in
     human lung adenocarcinoma. Cancer Res. 2002;62:7001�7003. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/12460919" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Ono M, Hirata A, Kometani T,
     Miyagawa M, Ueda S, Kinoshita H, Fujii T, Kuwano M. Sensitivity to
     gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines
     correlates with dependence on the epidermal growth factor (EGF)
     receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt
     pathway for proliferation. Mol Cancer Ther. 2004;3:465�472. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/15078990" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Onozato R, Kosaka T, Achiwa
     H, Kuwano H, Takahashi T, Yatabe Y, Mitsudomi T. LKB1 gene mutations in
     Japanese lung cancer patients. Cancer Sci. 2007;98:174�175. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/17711506" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Pham D, Kris MG, Riely GJ,
     Sarkaria IS, McDonough T, Chuai S, Venkatraman ES, Miller VA, Ladanyi M,
     Pao W, Wilson RK, Singh B, Rusch VW. Use of cigarette-smoking history to
     estimate the likelihood of mutations in epidermal growth factor receptor
     gene exons 19 and 21 in lung adenocarcinomas. J Clin Oncol.
     2006;24:1700�1704. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/16505411" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Sanchez-Cespedes M, Parrella
     P, Esteller M, Nomoto S, Trink B, Engles JM, Westra WH, Herman JG,
     Sidransky D. Inactivation of LKB1/STK11 is a common event in
     adenocarcinomas of the lung. Cancer Res. 2002;62:3659�3662. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/12097271" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Shaw RJ, Bardeesy N, Manning
     BD, Lopez L, Kosmatka M, DePinho RA, Cantley LC. The LKB1 tumor suppressor
     negatively regulates mTOR signaling. Cancer Cell. 2004;6:91�99. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/15261145" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Tiainen M, Ylikorkala A,
     Makela TP. Growth suppression by Lkb1 is mediated by a G(1) cell cycle
     arrest. Proc Natl Acad Sci USA. 1999;96:9248�9251. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC17765/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PMC free
     article</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]
     [</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/10430928"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Tracy S, Mukohara T, Hansen
     M, Meyerson M, Johnson BE, Janne PA. Gefitinib induces apoptosis in the
     EGFRL858R non-small-cell lung cancer cell line H3255. Cancer Res.
     2004;64:7241�7244. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/15492241" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
 <li class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif"'>Volikos E, Robinson J,
     Aittomaki K, Mecklin JP, Jarvinen H, Westerman AM, de Rooji FW, Vogel T,
     Moeslein G, Launonen V, Tomlinson IP, Silver AR, Aaltonen LA. LKB1 exonic
     and whole gene deletions are a common cause of Peutz-Jeghers syndrome. J
     Med Genet. 2006;43:e18. [</span><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564523/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PMC free
     article</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]
     [</span><a href="http://www.ncbi.nlm.nih.gov/pubmed/16648371"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>PubMed</span></a><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif"'>]</span></li>
</ul>

<p class=MsoNormal>&nbsp;</p>

</div>

</body>

</html>
